<SEC-DOCUMENT>0000010795-25-000019.txt : 20250205
<SEC-HEADER>0000010795-25-000019.hdr.sgml : 20250205
<ACCEPTANCE-DATETIME>20250205163229
ACCESSION NUMBER:		0000010795-25-000019
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20250205
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250205
DATE AS OF CHANGE:		20250205

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BECTON DICKINSON & CO
		CENTRAL INDEX KEY:			0000010795
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				220760120
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-04802
		FILM NUMBER:		25593813

	BUSINESS ADDRESS:	
		STREET 1:		ONE BECTON DR
		CITY:			FRANKLIN LAKES
		STATE:			NJ
		ZIP:			07417-1880
		BUSINESS PHONE:		2018476800

	MAIL ADDRESS:	
		STREET 1:		ONE BECTON DR
		CITY:			FRANKLIN LAKE
		STATE:			NJ
		ZIP:			07417
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bdx-20250205.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:a17b5a9c-6085-49b3-b1b7-4455cd2e45ff,g:5794aaff-59c8-4a79-93e5-b917e5904b6f,d:d3548cc83f5e49ea8d1f9df3c4f06176-->
<html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:bdx="http://www.bd.com/20250205" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bdx-20250205</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-42">0000010795</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-43">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bdx-20250205.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-05</xbrli:startDate><xbrli:endDate>2025-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-05</xbrli:startDate><xbrli:endDate>2025-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.900dueDecember152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-05</xbrli:startDate><xbrli:endDate>2025-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes3.020dueMay242025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-05</xbrli:startDate><xbrli:endDate>2025-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.208dueJune42026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-05</xbrli:startDate><xbrli:endDate>2025-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1213DueFebruary122036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-05</xbrli:startDate><xbrli:endDate>2025-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0034DueAugust132025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-05</xbrli:startDate><xbrli:endDate>2025-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes3.519DueFebruary82031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-05</xbrli:startDate><xbrli:endDate>2025-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes3.828DueJune72032Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-05</xbrli:startDate><xbrli:endDate>2025-02-05</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="id3548cc83f5e49ea8d1f9df3c4f06176_1"></div><div style="min-height:18pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="margin-top:19.8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CURRENT REPORT PURSUANT TO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECTION 13 OR 15(D) OF THE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:19.8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported) <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">February&#160;5, 2025</ix:nonNumeric></span></div><div style="margin-top:24.8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:19.8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">BECTON, DICKINSON AND COMPANY</ix:nonNumeric></span></div></td></tr><tr><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Exact Name of Registrant as Specified in Its Charter)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:19.8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">New Jersey</ix:nonNumeric></span></div></td></tr><tr><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of Incorporation)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.081%"><tr><td style="width:1.0%"/><td style="width:15.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.111%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.181%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-4802</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">22-0760120</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">1 Becton Drive,</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Franklin Lakes,</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">New Jersey</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">07417-1880</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:13.2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.257%"><tr><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.255%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.255%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:13.2pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">(201)</ix:nonNumeric>&#160;</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:13.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">847-6800</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="18" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(Registrant&#8217;s Telephone Number, Including Area Code)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:13.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></div></td></tr><tr><td colspan="18" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Former Name or Former Address, if Changed Since Last Report)</span></div></td></tr></table></div><div style="margin-top:8.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6.6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K Filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:92.322%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230425)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:92.322%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:92.322%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:92.322%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:18pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Title of Each Class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">which registered</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:Security12bTitle" id="f-17">Common stock, par value $1.00</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:TradingSymbol" id="f-18">BDX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-3" name="dei:Security12bTitle" id="f-20">1.900% Notes due December 15, 2026</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-3" name="dei:TradingSymbol" id="f-21">BDX26</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-3" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-22">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-4" name="dei:Security12bTitle" id="f-23">3.020% Notes due May 24, 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-4" name="dei:TradingSymbol" id="f-24">BDX25</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-4" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-25">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-5" name="dei:Security12bTitle" id="f-26">1.208% Notes due June 4, 2026</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-5" name="dei:TradingSymbol" id="f-27">BDX/26A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-5" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-28">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-6" name="dei:Security12bTitle" id="f-29">1.213% Notes due February 12, 2036</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-6" name="dei:TradingSymbol" id="f-30">BDX/36</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-6" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-31">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-7" name="dei:Security12bTitle" id="f-32">0.034% Notes due August 13, 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-7" name="dei:TradingSymbol" id="f-33">BDX25A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-7" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-34">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-8" name="dei:Security12bTitle" id="f-35">3.519% Notes due February 8, 2031</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-8" name="dei:TradingSymbol" id="f-36">BDX31</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-8" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-37">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-9" name="dei:Security12bTitle" id="f-38">3.828% Notes due June 7, 2032</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-9" name="dei:TradingSymbol" id="f-39">BDX32A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-9" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-40">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:96.122%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.578%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6.6pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6.6pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-41">&#9744;</ix:nonNumeric></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6.6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#9744;</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="id3548cc83f5e49ea8d1f9df3c4f06176_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;2.02&#160;&#160;&#160;&#160;RESULTS OF OPERATIONS AND FINANCIAL CONDITION.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;5, 2025, Becton, Dickinson and Company (&#8220;BD&#8221;) issued a press release announcing its financial results for its first fiscal quarter ending December&#160;31, 2024.  A copy of the press release is furnished as Exhibit 99.1 to this report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The press release furnished as Exhibit 99.1 contains certain financial measures that differ from those presented in accordance with U.S. generally accepted accounting principles (&#8220;non-GAAP measures&#8221;). Details regarding these non-GAAP measures and adjustments can be found in the schedules included in the press release furnished as Exhibit 99.1. </span></div><div><span><br/></span></div><div><span><br/></span></div><div id="id3548cc83f5e49ea8d1f9df3c4f06176_181"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7.01&#160;&#160;&#160;&#160;REGULATION FD DISCLOSURE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 5, 2025, BD issued a press release announcing its board of directors has unanimously authorized BD management to pursue a plan to separate its Biosciences and Diagnostic Solutions business from the rest of BD. BD expects to announce more specifics on the separation plans by the end of fiscal 2025 and intends to target completion of the transaction in fiscal 2026. The completion of any separation transaction will be contingent upon various conditions and approvals, including approval of BD&#8217;s board of directors, receipt of requisite regulatory clearances and compliance with applicable U.S. Securities and Exchange Commission requirements. No assurance can be given regarding the form that a separation transaction may take or the specific terms or timing, or that a separation will in fact occur.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of the press release is attached hereto as Exhibit 99.2 and incorporated into this Item 7.01 by reference.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in this Item 7.01 shall neither be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="id3548cc83f5e49ea8d1f9df3c4f06176_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;9.01&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND EXHIBITS.</span></div><div style="margin-top:13.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ex99112312024.htm">99.1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;Press release dated February&#160;5, 2025, which is furnished pursuant to Item&#160;2.02.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="bd_newsxbdbxdsxseparationp.htm">99.2</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;Press release dated February 5, 2025, which is furnished pursuant to Item 7.01.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 104&#160;&#160;&#160;&#160;Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="id3548cc83f5e49ea8d1f9df3c4f06176_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURES</span></div><div style="margin-top:6.6pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span><br/></span></div><div style="text-indent:256.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BECTON, DICKINSON AND COMPANY</span></div><div style="text-indent:256.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant)</span></div><div style="text-align:right;text-indent:279pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.707%"><tr><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:89.489%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Stephanie M. Kelly</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephanie M. Kelly</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Securities and Governance Counsel, Corporate Secretary</span></td></tr></table></div><div style="margin-top:14.8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: February&#160;5, 2025 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99112312024.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="id954c301d93f4f7c87c62bb39320c17a_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1 Becton Drive</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Franklin Lakes, NJ 07417</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">www.bd.com</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><img alt="image.jpg" src="image.jpg" style="height:114px;margin-bottom:5pt;vertical-align:text-bottom;width:275px"></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Contacts&#58;</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Investors&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Adam Reiffe, Sr. Director, Investor Relations - 201-847-6927</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Media&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Troy Kirkpatrick, VP, Public Relations - 858-617-2361</font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">BD Reports First Quarter Fiscal 2025 Financial Results</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:112%">Company Delivers Revenue, Margin and Earnings Ahead of its Expectations</font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Revenue of $5.2 billion increased 9.8% as reported, 9.6% currency-neutral and 3.9% organic</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">GAAP and adjusted diluted EPS of $1.04 and $3.43 grew 8.3% and 28.0%, respectively</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">BD completes $750 million share repurchase to date in FY25</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Company increases FY25 adjusted diluted EPS guidance at the midpoint while absorbing translational currency</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">1</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">FRANKLIN LAKES, NJ (February&#160;5, 2025) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">- BD (Becton, Dickinson and Company) (NYSE&#58; BDX), a leading global medical technology company, today announced results for its fiscal 2025 first quarter which ended December&#160;31, 2024. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8220;We delivered strong operational performance in Q1, with revenue growth, margin expansion and earnings per share all ahead of our expectations,&#8221; said Tom Polen, chairman, CEO and president of BD. &#8220;We continue to transform our company through BD 2025, and our intention to separate Biosciences and Diagnostic Solutions builds on the strong foundation and momentum of our strategy. This separation is designed to unlock significant value for both &#8216;New BD&#8217; and Biosciences and Diagnostic Solutions as each focuses on maximizing growth, delivering leading innovation and operational excellence in their respective markets. Our talented teams continue to drive solid execution of BD 2025 and meaningful innovation in these businesses and across BD.&#8221;</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:112%">BD does not attempt to provide reconciliations of forward-looking adjusted diluted EPS guidance to the comparable GAAP measure. See the discussion below under &#34;Assumptions and Outlook for Full Year Fiscal 2025.&#34;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Recent Business Highlights</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.53pt">The company announced the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">BD board authorized the repurchase of up to 10 million shares of BD common stock</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> in addition to the shares that remain available under the board's previous authorization in 2021.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.53pt">BD Medical&#58; </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.53pt">The </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Medication Delivery Solutions</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> business unit announced&#58;</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:14.25pt">Additional </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">investments in its U.S. manufacturing network to add capacity for critical medical devices</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">, including syringes, needles and IV catheters, to meet the ongoing needs of the nation's health care system.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page 1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:14.25pt">Carilion Clinic is the first health system in Virginia to offer needle-free in-patient blood draws using the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">BD&#174; PIVO&#8482; Pro Needle-free Blood Collection Device</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">, redefining the standard of care for patients and delivering on the vision of a </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">&#34;One-Stick Patient Experience.&#34;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.53pt">BD Life Sciences&#58;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.53pt">The </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Specimen Management</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> business unit announced an expansion of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">innovative fingertip blood testing</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> for use by U.S. health systems and other large provider networks in settings like urgent cares, doctor offices and other ambulatory care settings. This blood testing process integrates </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">BD's MiniDraw&#8482; Capillary Blood Collection System </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">with Babson's BetterWay technologies.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.53pt">The </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Diagnostic Solutions</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> business unit announced the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">BD Onclarity&#8482; HPV Assay </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">has officially been added to the American Society for Colposcopy and Cervical Pathology (ASCCP) Enduring Risk-Based Management Guidelines, due to its ability to individually identify more high-risk types of HPV than any other test on the market. The company also announced the assay will be used in a first of its kind </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Human Papillomavirus (HPV) self-collection study</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> to improve cervical cancer screening in underserved communities. The BD Onclarity&#8482; HPV Assay was approved earlier this year by the U.S. Food and Drug Administration (FDA) for HPV self-collection screening in health care settings.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.53pt">The </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Biosciences </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">business unit announced a collaboration with Biosero to enable </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">robotic integration with BD flow cytometers</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> to accelerate drug discovery and development.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">First Quarter Fiscal 2025 Operating Results</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.861%"><tr><td style="width:1.0%"></td><td style="width:33.014%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.592%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended December 31,</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reported Change</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Currency Neutral Change</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Organic Revenue Change</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1,2</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars, except per share amounts)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,168&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,706&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Diluted Earnings per Share</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.04&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.96&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted Diluted Earnings per Share</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.43&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.68&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="padding-left:76.5pt;padding-right:99pt"><font><br></font></div><div style="padding-left:99pt;padding-right:99pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents a non-GAAP financial measure&#59; refer to reconciliations of non-GAAP financial measures included in the attached financial tables. </font></div><div style="padding-left:99pt;padding-right:99pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Organic Revenue growth denotes foreign currency neutral revenues further adjusted for the impact to revenues from acquisitions and divestitures during the first 12 months post-acquisition&#47;divestiture.</font></div><div style="padding-left:99pt;padding-right:99pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Geographic Results</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.694%"><tr><td style="width:1.0%"></td><td style="width:27.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.906%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.633%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> (Millions of dollars)</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended December 31,</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reported Change</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" rowspan="2" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Currency Neutral Change</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">United States</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,080&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,749&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,089&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,957&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</font></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,168&#160;</font></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,706&#160;</font></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</font></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</font></td><td style="border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="padding-left:99pt;padding-right:99pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents a non-GAAP financial measure&#59; refer to reconciliations of non-GAAP financial measures included in the attached financial tables. </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Segment Results</font></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page 2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.944%"><tr><td style="width:1.0%"></td><td style="width:24.126%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.857%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.857%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.404%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.404%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.404%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.952%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> (Millions of dollars)</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended December 31,</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reported Change</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Currency Neutral Change</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Organic Revenue Change</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1,2</font></div></td></tr><tr style="height:17pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BD Medical</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,615&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,230&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:6pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BD Life Sciences</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,297&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,288&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</font></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:6pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BD Interventional</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</font></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:6pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,168&#160;</font></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,706&#160;</font></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</font></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</font></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</font></td><td style="border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  </font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:99pt;padding-right:99pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents a non-GAAP financial measure&#59; refer to reconciliations of non-GAAP financial measures included in the attached financial tables.</font></div><div style="padding-left:99pt;padding-right:99pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Organic Revenue growth denotes foreign currency neutral revenues further adjusted for the impact to revenues from acquisitions and divestitures during the first 12 months post-acquisition&#47;divestiture.  </font></div><div style="padding-left:99pt;padding-right:85.5pt"><font><br></font></div><div style="padding-left:99pt;padding-right:85.5pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">The BD Medical segment</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> includes the Medication Delivery Solutions (MDS), Medication Management Solutions (MMS) and Pharmaceutical Systems (PS) business units, and the Advanced Patient Monitoring (APM) business unit. BD Medical performance reflects the revenue contribution from APM, which was formed upon the closing of the acquisition of Critical Care from Edwards Lifesciences on September 3, 2024. BD Medical organic revenue growth was led by MDS and MMS.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:12.53pt">MDS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> performance reflects increased volumes and share gains in Vascular Access Management and strong performance in hypodermic products.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:12.53pt">MMS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> performance reflects double-digit growth in Infusion driven by BD Alaris&#8482; that was partially offset by capital seasonality and the prior-year comparisons in Dispensing Solutions and Pharmacy Automation.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:12.53pt">PS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> performance reflects timing in Biologics and transitory market dynamics that resulted in lower demand for prefillable syringes.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">The BD Life Sciences segment</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> includes the Specimen Management (SM), Diagnostic Solutions (DS) and Biosciences (BDB) business units. BD Life Sciences revenue growth was driven by performance in SM and DS.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:12.53pt">SM</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> performance reflects broad volume strength across the BD Vacutainer&#8482; portfolio and customer upgrades to clinically differentiated, higher-value products.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:12.53pt">DS </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">performance reflects strength in BD Kiestra&#8482; Lab Automation and BD MAX&#8482; IVD that was partially offset by the delayed start to the U.S. respiratory season.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:12.53pt">BDB</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> performance reflects transitory market dynamics that resulted in lower demand for research solutions in China and the U.S. as expected, partially offset by licensing revenue and double-digit growth in U.S. clinical solutions.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">The BD Interventional segment</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> includes the Surgery, Peripheral Intervention (PI), and Urology &#38; Critical Care (UCC) business units.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">BD Interventional</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">revenue growth was driven by performance across the segment.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:12.53pt">Surgery </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">performance reflects double-digit growth in Infection Prevention and Phasix&#8482; hernia resorbable scaffold.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:12.53pt">PI</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> performance reflects strong growth in the Peripheral Vascular Disease and End Stage Kidney Disease portfolios that was partially offset by the expected impact of volume-based procurement in China, primarily in our Oncology business.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:12.53pt">UCC </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">performance reflects double-digit growth in the PureWick&#8482; franchise with continued adoption of the Male and Female portfolios.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Assumptions and Outlook for Full Year Fiscal 2025</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The company provided the following guidance with respect to fiscal 2025. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The company updated its fiscal 2025 guidance to reflect strong operational performance in its fiscal first quarter and confidence in its full-year outlook. The company increased its Adjusted Diluted EPS guidance to a range of $14.30 to $14.60, which reflects growth of 10% at the midpoint. This reflects an operational increase of $0.175 compared to its </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page 3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">previously issued guidance, which is enabling it to absorb the estimated impact of incremental translational foreign currency of $0.15.</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.861%"><tr><td style="width:1.0%"></td><td style="width:41.015%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal 2025 Guidance as of February 5, 2025</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal 2025 Guidance as of November 7, 2024</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP Revenues</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#126;$21.7 to $21.9 billion</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#126;$21.9 to $22.1 billion</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP Revenue Growth</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9% to 8.4%</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9% to 9.4%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted Revenue Growth (FXN)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8% to 9.3%</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8% to 9.3%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Organic Revenue Growth (FXN)</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0% to 4.5%</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0% to 4.5%</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted Diluted EPS</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14.30 to $14.60</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14.25 to $14.60</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted Diluted EPS Growth</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#126;8.8% to 11.0%</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#126;8.5% to 11.0%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">BD's outlook for fiscal 2025 reflects numerous assumptions about many factors that could affect its business, based on the information management has reviewed as of this date. Management will discuss its outlook and several of its assumptions on its first fiscal quarter earnings call. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The company's expected adjusted diluted EPS for fiscal 2025 excludes potential charges or gains that may be recorded during the fiscal year, such as, among other things, the non-cash amortization of intangible assets, acquisition-related charges, spin-related costs, and certain tax matters. BD does not attempt to provide reconciliations of forward-looking adjusted diluted non-GAAP EPS guidance to the comparable GAAP measure because the impact and timing of these potential charges or gains are inherently uncertain and difficult to predict and are unavailable without unreasonable efforts. In addition, the company believes such reconciliations would imply a degree of precision and certainty that could be confusing to investors. Such items could have a material impact on GAAP measures of BD&#8217;s financial performance. We also present our estimated adjusted revenue growth and organic revenue growth for our 2025 fiscal year after adjusting for the illustrative impact of foreign currency translation. BD believes that this adjustment allows investors to better evaluate BD&#8217;s anticipated underlying earnings performance for our 2025 fiscal year in relation to our underlying 2024 fiscal year performance.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Conference Call and Presentation Materials</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">BD will host an audio webcast tomorrow for the public, investors, analysts, and news media to discuss its first quarter results. The audio webcast will be broadcast live on BD&#8217;s website, www.bd.com&#47;investors at 8 a.m. (ET)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Thursday, February 6, 2025. Accompanying slides are available on BD&#8217;s website, www.bd.com&#47;investors. The conference call will be available for replay on BD&#8217;s website, www.bd.com&#47;investors. Alternatively, you can dial into the replay at 800-839-2486 (domestic) and 402-220-7223 (international) through the close of business on Thursday, February 13, 2025. A confirmation number is not needed to access the replay.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Non-GAAP Financial Measures&#47;Financial Tables</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">This news release contains certain non-GAAP financial measures. These include revenue growth rates on a currency-neutral and organic basis and adjusted diluted earnings per share. These non-GAAP financial measures are not in accordance with generally accepted accounting principles in the United States.&#160;BD management believes that the use of non-GAAP measures to adjust for items that are considered by management to be outside of BD&#8217;s underlying operational results or that affect period to period comparability helps investors to gain a better understanding of our performance year-over-year, to analyze underlying trends in our businesses, to analyze our operating results, and to understand future prospects. Management uses these non-GAAP financial measures to measure and forecast the company&#8217;s performance, especially when comparing such results to previous periods or forecasts. We believe presenting such adjusted metrics provides investors with greater transparency to the information used by BD management for its operational decision-making and for comparison to other companies within the medical technology industry. Although BD&#8217;s management believes non-GAAP results are useful in evaluating the performance of its business, its reliance on these measures is limited since items excluded from such measures may have a material impact on BD&#8217;s net income, earnings per share or cash flows calculated in accordance with GAAP. Therefore, management typically uses non-GAAP results in conjunction with GAAP results to address these limitations. BD strongly encourages investors to review its consolidated financial statements and publicly filed reports in their entirety and cautions investors that the non-GAAP measures used by BD may differ from similar measures used by other companies, even when similar terms are used to </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page 4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">identify such measures. Non-GAAP measures should not be considered replacements for, and should be read together with, the most comparable GAAP financial measures. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">We present adjusted diluted earnings per share for the first quarter of fiscal year 2025, and the corresponding prior periods, after eliminating items we believe are not part of our ordinary operations and affect the comparability of the periods presented. Adjusted diluted earnings per share includes adjustments for the impact of purchase accounting adjustments, integration and restructuring costs, transaction costs, spin-off related costs, certain regulatory costs, certain product remediation costs, certain legal matters, certain investment gains and losses, certain asset impairment charges, and certain pension settlement costs. In particular, prior-year adjusted diluted earnings per share results exclude European regulatory initiative-related costs, which represent costs incurred to develop processes and systems to establish initial compliance with the European Union Medical Device Regulation and the European Union In Vitro Diagnostic Medical Device Regulation (collectively, the &#8220;New EU Medical Devices Regulations&#8221;), which represent a significant, unusual change to the existing regulatory framework. We consider the excluded European regulatory initiative-related costs to be duplicative of previously incurred costs and&#47;or one-off costs related to establishing initial compliance with such regulatory regimes, and in each case are limited to a specific period of time. These expenses relate to establishing initial compliance with the New EU Medical Devices Regulations and include the cost of labor, other services and consulting (in particular, research and development and clinical trials) and supplies, travel and other miscellaneous costs. These costs were recorded in </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">Cost of products sold</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">Research and development expense</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">We also present revenue growth rates for the first quarter of fiscal year 2025 over the corresponding prior periods on a currency-neutral basis after eliminating the effect of foreign currency translation, where applicable. We also show the growth in adjusted diluted earnings per share compared to the prior year periods after eliminating the impact of foreign currency translation to further enable investors to evaluate BD&#8217;s underlying earnings performance compared to the prior periods. We calculate foreign currency-neutral percentages by converting our current-period local currency financial results using the prior period foreign currency exchange rates and comparing these adjusted amounts to our current-period results. As exchange rates are an important factor in understanding period-to-period comparisons, we believe the presentation of results on a foreign currency-neutral basis in addition to reported results helps improve investors&#8217; ability to understand our operating results and evaluate our performance in comparison to the prior periods. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Reconciliations of these and other non-GAAP measures to the comparable GAAP measures are included in the attached financial tables. Within the attached financial tables presented, certain columns and rows may not add due to the use of rounded numbers. Percentages and earnings per share amounts presented are calculated from the underlying amounts.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">About BD</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians&#8217; care delivery process, enable laboratory scientists to accurately detect disease and advance researchers&#8217; capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com&#47;company&#47;bd1&#47; and on X (formerly known as Twitter) &#64;BDandCo. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">***</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">This press release and accompanying audio webcast on February 6, 2025 contain certain estimates and other forward-looking statements (as defined under Federal securities laws) regarding BD&#8217;s future prospects and performance, including, but not limited to, statements relating to future revenues, margins, earnings per share, leverage targets and capital deployment. All such statements are based upon current expectations and assumptions of BD and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described, implied or projected in any forward-looking statement. With respect to such forward-looking statements, a number of factors could cause actual results to vary materially. These factors include, but are not limited to, risks relating to macroeconomic conditions and their impact on our operations and healthcare spending generally, including any impact of disruptions in the global transportation networks or other aspects of our supply chain on our ability to source raw materials, components and energy sources needed to produce our products, labor constraints or disputes, inflationary pressures, currency rate fluctuations, and increased interest rates and borrowing costs&#59; conditions in international </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page 5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">markets, including geopolitical developments such as the evolving situations in Russia and Ukraine, the Middle East and Asia, which could adversely impact our operations&#59; competitive factors including technological advances and new products or novel medical therapies introduced by competitors&#59; product efficacy or safety concerns or non-compliance with applicable regulatory requirements (such as non-compliance of our products with registration requirements resulting from modifications to such products, or other factors, including with respect to BD Alaris&#8482; pumps and related sets and BD Vacutainer&#8482;) resulting in product recalls, lost revenue or other actions being taken with respect to products in the field or the ability to continue selling new products to customers&#59; changes to legislation or regulations impacting the U.S. or foreign healthcare systems, changes in medical practices or in patient preferences, potential cuts or freezes in governmental research or other healthcare spending, or governmental or private measures to contain healthcare costs, such as China&#8217;s volume-based procurement tender process or changes in pricing and reimbursement policies, which could result in reduced demand for our products or downward pricing pressure&#59; new or changing laws and regulations impacting our business (including the imposition of tariffs, such as those relating to China, Mexico, or other countries and regions in which we do business, sanctions, changes in tax laws, new environmental laws and regulations (such as those related to climate change or materials of concern), new cybersecurity, artificial intelligence or privacy laws, or changes in laws impacting international trade, including import and export licensing requirements, or anti-corruption and bribery, or changes in reporting requirements or enforcement practices with respect to such laws&#59; the adverse impact on our business or products of past, current or future information and technology system disruptions, breaches or breakdowns, including through cyberattacks, ransom attacks or cyber-intrusion, and any investigations, legal proceedings, liability, expense or reputational damage arising in connection with any such events&#59; increased labor costs and labor shortages or disputes&#59; our suppliers&#8217; ability to provide products needed for our operations and BD&#8217;s ability to maintain favorable supplier arrangements and relationships&#59; increases in energy costs and their effect on, among other things, the cost of producing BD&#8217;s products&#59; adverse changes in regional, national or foreign economic conditions, including any impact on our ability to access credit markets and finance our operations&#59; risks relating to our overall indebtedness&#59; the possible impact of public health crises on our business and the global healthcare system, which could decrease demand for our products,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">disrupt our operations or the operations of our customers and companies within our supply chain, or increase transportation costs&#59; interruptions in our manufacturing or sterilization processes or those of our third-party providers, including any restrictions placed on the use of ethylene oxide for sterilization&#59; pricing and market pressures&#59; difficulties inherent in product development, delays in product introductions and uncertainty of market acceptance of new products&#59; the overall timing of the replacement or remediation of the BD Alaris&#8482; Infusion System and return to market in the U.S., which may be impacted by, among other things, customer readiness, supply continuity and our continued engagement with the FDA&#59; our ability to achieve our projected level or mix of product sales&#59; our ability to successfully integrate any businesses we acquire&#59; uncertainties of litigation, investigations, subpoenas, settlements, fines, penalties and&#47;or other sanctions (as described in BD&#8217;s filings with the Securities and Exchange Commission (&#34;SEC&#34;))&#59; the issuance of new or revised accounting standards&#59; risks associated with the impact, timing or terms of the contemplated separation of BD&#8217;s Biosciences and Diagnostic Solutions business&#59; risks associated with the expected benefits and costs of the contemplated separation, including the risk that the expected benefits of the separation will not be realized within the expected time frame, in full or at all, and the risk that any conditions to the separation will not be satisfied and&#47;or that the separation will not be completed within the anticipated time frame, on the anticipated terms or at all&#59; the risk that any consents or approvals required in connection with the contemplated separation will not be received or obtained within the expected time frame, on the expected terms or at all&#59; the risk that dis-synergy costs, costs of restructuring transactions and other costs incurred in connection with the contemplated separation will exceed BD&#8217;s estimates&#59; the impact of the contemplated separation on BD&#8217;s businesses and the risk that the contemplated separation may be more difficult, time-consuming or costly than expected, including the impact on BD&#8217;s resources, systems, procedures and controls, diversion of management&#8217;s attention and the impact on relationships with customers, suppliers, employees and other business counterparties, as well as other factors discussed in BD&#8217;s filings with the SEC. There can be no assurance</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">that the contemplated separation will in fact be completed, in the manner described or at all. We do not intend to update any forward-looking statements to reflect events or circumstances after the date hereof except as required by applicable laws or regulations.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page 6</font></div></div></div><div id="id954c301d93f4f7c87c62bb39320c17a_4"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BECTON DICKINSON AND COMPANY</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED INCOME STATEMENTS</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Unaudited&#59; Amounts in millions, except share and per share data)</font></div><div><font><br></font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.093%"><tr><td style="width:1.0%"></td><td style="width:59.343%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.463%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.463%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.027%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended December 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%&#160;Change</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">REVENUES</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,168&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,706&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,933&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,679&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration, restructuring and transaction expense</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL OPERATING COSTS AND EXPENSES</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,715&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,267&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OPERATING INCOME</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.5)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279.8)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INCOME BEFORE INCOME TAXES</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.7)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.4)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NET INCOME</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic Earnings per Share</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.05&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.97&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings per Share</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.04&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.96&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AVERAGE SHARES OUTSTANDING (in thousands)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,505</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,113</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,389</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,398</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.900%"><tr><td style="width:1.0%"></td><td style="width:61.067%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.546%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.546%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.548%"></td><td style="width:0.1%"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page 1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BECTON DICKINSON AND COMPANY</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Amounts in millions)</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.555%"><tr><td style="width:1.0%"></td><td style="width:58.246%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.159%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.595%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2024</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Unaudited)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASSETS</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,717&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,638&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,033&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,860&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,843&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,331&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL CURRENT ASSETS</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,659&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,468&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,602&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,821&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other intangibles, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,817&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,383&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,586&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,615&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL ASSETS</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,665&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,286&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIABILITIES AND SHAREHOLDERS' EQUITY</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,170&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,347&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,786&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,440&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,940&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term employee benefit obligations</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes and other liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,418&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,558&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,205&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,890&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,665&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,286&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page 2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BECTON DICKINSON AND COMPANY</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Unaudited&#59; Amounts in millions)</font></div><div><font><br></font></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.005%"><tr><td style="width:1.0%"></td><td style="width:64.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.296%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.199%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.921%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OPERATING ACTIVITIES</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities and other, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NET CASH PROVIDED BY CONTINUING OPERATING ACTIVITIES </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">693&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INVESTING ACTIVITIES</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturities and sales of investments</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NET CASH PROVIDED BY (USED FOR) INVESTING ACTIVITIES</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FINANCING ACTIVITIES</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in short-term debt</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments of debt</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(875)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchases of common stock</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(500)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(275)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NET CASH USED FOR FINANCING ACTIVITIES</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,928)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(862)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for operating activities of discontinued operations</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and equivalents and restricted cash</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NET DECREASE IN CASH AND EQUIVALENTS AND RESTRICTED CASH</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,043)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OPENING CASH AND EQUIVALENTS AND RESTRICTED CASH</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,856&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CLOSING CASH AND EQUIVALENTS AND RESTRICTED CASH</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,234&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page 3</font></div></div></div><div id="id954c301d93f4f7c87c62bb39320c17a_7"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BECTON DICKINSON AND COMPANY</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SUPPLEMENTAL REVENUE INFORMATION</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">REVENUES BY BUSINESS SEGMENTS AND UNITS - UNITED STATES</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Three Months Ended December 31, </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Unaudited&#59; Amounts in millions)</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:56.989%"><tr><td style="width:1.0%"></td><td style="width:50.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.546%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">A</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">B</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C&#61;(A-B)&#47;B</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% Change</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">BD MEDICAL</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Delivery Solutions</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Management Solutions</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Systems</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.5)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Patient Monitoring</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,615&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,360&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">BD LIFE SCIENCES</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specimen Management </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostic Solutions </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biosciences</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">BD INTERVENTIONAL</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Intervention</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Critical Care</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL UNITED STATES</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,080&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,749&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:8.2pt;padding-left:166.5pt;padding-right:148.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#34;NM&#34; denotes that the percentage change is not meaningful. </font></div><div style="margin-top:6pt;padding-left:166.5pt;padding-right:144pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)  During the first quarter of fiscal year 2025, Life Sciences split its former Integrated Diagnostic Solutions organizational unit into two units to better align BD resources with the distinct needs of each business.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page 4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BECTON DICKINSON AND COMPANY</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SUPPLEMENTAL REVENUE INFORMATION</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">REVENUES BY BUSINESS SEGMENTS AND UNITS - INTERNATIONAL</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Three Months Ended December 31, (continued)</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Unaudited&#59; Amounts in millions)</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.817%"><tr><td style="width:1.0%"></td><td style="width:36.868%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.368%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.831%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.368%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.368%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.368%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.686%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">D&#61;(A-B)&#47;B</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E&#61;(A-B-C)&#47;B</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">A</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">B</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% Change</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FX Impact</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reported</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FXN</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">BD MEDICAL</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Delivery Solutions</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Management Solutions </font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Systems</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Patient Monitoring</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">BD LIFE SCIENCES</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specimen Management </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostic Solutions </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biosciences</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.7)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">BD INTERVENTIONAL</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Intervention</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Critical Care</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL INTERNATIONAL</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,089&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,957&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:8.2pt;padding-left:135pt;padding-right:148.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#34;NM&#34; denotes that the percentage change is not meaningful. </font></div><div style="margin-top:6pt;padding-left:135pt;padding-right:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)  During the first quarter of fiscal year 2025, Life Sciences split its former Integrated Diagnostic Solutions organizational unit into two units to better align BD resources with the distinct needs of each business.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page 5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BECTON DICKINSON AND COMPANY</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SUPPLEMENTAL REVENUE INFORMATION</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">REVENUES BY BUSINESS SEGMENTS AND UNITS - TOTAL</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Three Months Ended December 31, (continued)</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Unaudited&#59; Amounts in millions)</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:67.849%"><tr><td style="width:1.0%"></td><td style="width:33.923%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.154%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">D&#61;(A-B)&#47;B</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E&#61;(A-B-C)&#47;B</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">A</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">B</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% Change</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FX&#160;Impact</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reported</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FXN</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">BD MEDICAL</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Delivery Solutions</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Management Solutions</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Systems</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Patient Monitoring</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,615&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,230&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">BD LIFE SCIENCES</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specimen Management </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostic Solutions </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biosciences</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,297&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,288&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">BD INTERVENTIONAL</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Intervention</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Critical Care</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL REVENUES</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,168&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,706&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:8.2pt;padding-left:135pt;padding-right:148.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#34;NM&#34; denotes that the percentage change is not meaningful. </font></div><div style="margin-top:6pt;padding-left:135pt;padding-right:108pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)  During the first quarter of fiscal year 2025, Life Sciences split its former Integrated Diagnostic Solutions organizational unit into two units to better align BD resources with the distinct needs of each business.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page 6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BECTON DICKINSON AND COMPANY</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SUPPLEMENTAL REVENUE INFORMATION</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">RECONCILIATION OF REPORTED REVENUE CHANGE TO ORGANIC REVENUE CHANGE</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Three Months Ended December 31, </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Unaudited&#59; Amounts in millions)</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.709%"><tr><td style="width:1.0%"></td><td style="width:45.757%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.575%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.053%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.575%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.053%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.575%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.053%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.575%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.550%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.575%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.059%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">D &#61; (A-B)&#47;B</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">E&#61;(A-B-C)&#47;B</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">A</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">B</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% Change</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FX&#160;Impact</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reported</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FXN</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL REVENUES</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,168&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,706&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58; Inorganic revenue adjustment</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organic Revenue</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,897&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,706&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BD MEDICAL REVENUES</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,615&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,230&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58; Inorganic revenue adjustment</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BD Medical Organic Revenue</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,343&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,230&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:8.2pt;padding-left:72pt;padding-right:148.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  &#34;NM&#34; denotes that the percentage change is not meaningful. </font></div><div style="margin-top:8.2pt;padding-left:90pt;padding-right:76.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Inorganic revenue adjustment is defined as the amount of incremental revenue attributable to acquisitions and the revenue decline attributable to divestitures during the first 12 months post-acquisition&#47;divestiture. Acquisitions include&#58; Advanced Patient Monitoring in the Medical Segment.</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.806%"><tr><td style="width:1.0%"></td><td style="width:46.612%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.924%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.851%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.032%"><tr><td style="width:1.0%"></td><td style="width:47.199%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.015%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.015%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.015%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.838%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.478%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:108pt;text-indent:-40.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.032%"><tr><td style="width:1.0%"></td><td style="width:47.199%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.015%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.015%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.015%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.838%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.478%"></td><td style="width:0.1%"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.129%"><tr><td style="width:1.0%"></td><td style="width:46.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.913%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.913%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.913%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.913%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.799%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:56.989%"><tr><td style="width:1.0%"></td><td style="width:50.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.546%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-right:148.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.817%"><tr><td style="width:1.0%"></td><td style="width:36.868%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.368%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.831%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.368%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.368%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.368%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.686%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:67.849%"><tr><td style="width:1.0%"></td><td style="width:33.923%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.154%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page 7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BECTON DICKINSON AND COMPANY</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SUPPLEMENTAL INFORMATION</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">RECONCILIATION OF REPORTED DILUTED EPS TO ADJUSTED DILUTED EPS</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Unaudited)</font></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.354%"><tr><td style="width:1.0%"></td><td style="width:56.475%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:4.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.986%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.826%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.078%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="display:none"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended December 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Translational FX</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FXN<br>Change</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change&#160;%</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FXN<br>Change&#160;%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported Diluted Earnings per Share</font></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.04&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.96&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting adjustments ($570 million and $362 million pre-tax, respectively) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.96&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.24&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration costs ($24 million and $5 million pre-tax, respectively) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs ($66 million and $69 million pre-tax, respectively) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.23&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.24&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction Costs ($3 million pre-tax) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </font></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation-related items ($2 million pre-tax, respectively) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European regulatory initiative-related costs ($23 million pre-tax, respectively)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (5)</font></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product, litigation, and other items ($102 million and $14 million pre-tax, respectively) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</font></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax impact of specified items and other tax related (($71) million and $24 million, respectively)</font></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.24)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted Diluted Earnings per Share</font></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.43&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.68&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.74&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6%</font></td></tr></table></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">Includes amortization and other adjustments related to the purchase accounting for acquisitions. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">Represents costs associated with integration and restructuring activities.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">Represents transaction costs recorded to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Integration, restructuring and transaction expense </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">incurred in connection with the Advanced Patient Monitoring acquisition.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">Represents costs recorded to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense, net</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> incurred in connection with the separation of BD's former Diabetes Care business.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">Represents costs incurred to develop processes and systems to establish initial compliance with the European Union Medical Device Regulation and the European Union In Vitro Diagnostic Medical Device Regulation, which represent a significant, unusual change to the existing regulatory framework. We consider these costs to be duplicative of previously incurred costs and&#47;or one-off costs, which are limited to a specific period of time. These expenses, which are recorded in </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Research and development expense</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, include the cost of labor, other services and consulting (in particular, research and development and clinical trials) and supplies, travel and other miscellaneous costs.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">Includes certain (income) expense items which are not part of ordinary operations and affect the comparability of the periods presented. Such items may include certain product remediation costs, certain legal matters, certain investment gains and losses, certain asset impairment charges, and certain pension settlement costs. The amount for the three months ended December 31, 2024 reflects a charge of $22 million to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to adjust the estimate of future product remediation costs, a charge of $30 million to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Research and development expense </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">related to a non-cash asset impairment charge in the Life Sciences segment, and charges of $29 million to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense, net, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">related to various legal matters.</font></div><div><font><br></font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.784%"><tr><td style="width:1.0%"></td><td style="width:57.412%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:4.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.231%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.231%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.072%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.231%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.042%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.231%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.611%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.231%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.287%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.231%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.046%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:4pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page 8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BECTON DICKINSON AND COMPANY</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SUPPLEMENTAL INFORMATION</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FY 2025 OUTLOOK RECONCILIATION</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.602%"><tr><td style="width:1.0%"></td><td style="width:49.385%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.200%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Full Year FY 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Full Year FY 2025 Outlook </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in millions)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BDX Reported Revenues</font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,178&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add&#58; Revenue Adjustment Impact</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted Revenues</font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,245&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FY 2025 Reported Revenue Growth</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+7.9% to +8.4%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue Adjustment Impact</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#126;+35 basis points</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illustrative Foreign Currency (FX) Impact</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(&#126;125) basis points</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FY 2025 Revenue Growth (adjusted) (FXN)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+8.8% to 9.3%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FY 2025 Inorganic Impact to Revenue Growth</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#126;+475 basis points</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FY 2025 Organic Revenue Growth (FXN)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+4.0% to +4.5%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total FY 2025 Revenues</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#126;$21.7 to $21.9 billion</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Notes</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">- Revenue Adjustment Impact reflects the recognition of accruals resulting from developments relating to the Italian government medical device pay back legislation, as well as another legal matter, and which substantially relate to years prior to fiscal year 2024.</font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">-  Inorganic revenue adjustment is defined as the amount of incremental revenue attributable to acquisitions and the revenue decline attributable to divestitures during the first 12 months post-acquisition&#47;divestiture. </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page 9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BECTON DICKINSON AND COMPANY</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SUPPLEMENTAL INFORMATION</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FY 2025 OUTLOOK RECONCILIATION CONTINUED</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.107%"><tr><td style="width:1.0%"></td><td style="width:59.997%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.231%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.231%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.491%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.635%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Full Year FY 2025 Outlook </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Full Year FY 2024 from Continuing Operations</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Company</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Diluted Earnings per Share</font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.86&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting adjustments ($1.503 billion pre-tax) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.16&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration costs ($23 million pre-tax) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs ($387 million pre-tax) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.33&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction Costs ($48 million pre-tax) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing Costs (($8) million pre-tax) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation-related items ($13 million pre-tax) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European regulatory initiative-related costs ($104 million pre-tax)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (5)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product, litigation, and other items ($346 million pre-tax) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.19&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax impact of specified items and other tax related (($297) million)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.02)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted Diluted Earnings per Share</font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.14&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14.30 to $14.60</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported % Change</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+8.8% to +11.0%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:18pt"><font><br></font></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">Includes amortization and other adjustments related to the purchase accounting for acquisitions. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">Represents costs associated with integration and restructuring activities.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">Represents transaction costs and financing impacts associated with the Advanced Patient Monitoring acquisition. The transaction costs are recorded in </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Integration, restructuring and transaction expense</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and the financing impacts are recorded in </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest income</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">Represents costs recorded to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense (income), net</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> incurred in connection with the separation of BD's former Diabetes Care business.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">Represents costs incurred to develop processes and systems to establish initial compliance with the European Union Medical Device Regulation and the European Union In Vitro Diagnostic Medical Device Regulation, which represent a significant, unusual change to the existing regulatory framework. We consider these costs to be duplicative of previously incurred costs and&#47;or one-off costs, which are limited to a specific period of time. These expenses, which are recorded in </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Research and development expense</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, include the cost of labor, other services and consulting (in particular, research and development and clinical trials) and supplies, travel and other miscellaneous costs.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8pt">Includes certain (income) expense items which are not part of ordinary operations and affect the comparability of the periods presented. Such items may include certain product remediation costs, certain legal matters, certain investment gains and losses, certain asset impairment charges, and certain pension settlement costs. The amount in 2024 reflects the recognition of $67 million in accruals as an impact to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Revenues</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> resulting from recent developments relating to the Italian government medical device pay back legislation, as well as another legal matter, and which substantially relate to years prior to our current fiscal year, and charges of $38 million to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to record or adjust future costs for  product remediation efforts. The amount in 2024 also reflects charges to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense (income)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> net</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> related to legal matters, including a $175 million charge to accrue an estimated liability for the SEC investigation with respect to, among other things, certain reporting issues involving BD Alaris</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">TM</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> infusion pumps included in SEC disclosures prior to 2021. </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page 10</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>bd_newsxbdbxdsxseparationp.htm
<DESCRIPTION>EX-99.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i61d8747d97be44a0977931b981c758a9_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:10pt"><img alt="image_0.jpg" src="image_0.jpg" style="height:113px;margin-bottom:5pt;vertical-align:text-bottom;width:275px"><font style="background-color:#ffffff;color:#044ed7;font-family:'Calibri',sans-serif;font-size:28pt;font-weight:400;line-height:120%">NEWS RELEASE</font></div><div style="margin-bottom:10pt"><font><br></font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;FOR IMMEDIATE RELEASE</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">BD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock Value</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:-18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:13.8pt">Compelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital allocation, and optimized market valuation </font></div><div style="padding-left:36pt;padding-right:-18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:13.8pt">&#8220;New BD,&#8221; built on momentum of BD 2025 strategy, will be well-positioned as a scaled, pure-play MedTech leader focused on attractive categories shaping the future of health care</font></div><div style="padding-left:36pt;padding-right:-18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:13.8pt">Biosciences and Diagnostic Solutions to realize its full market potential as differentiated leader in Life Sciences Tools and Diagnostics, with robust innovation pipeline and headroom for growth in key sectors</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">FRANKLIN LAKES, N.J. (Feb. 5, 2025) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8211; BD (Becton, Dickinson and Company) (NYSE&#58; BDX), a leading global medical technology company, today announced its board of directors has unanimously authorized BD management to pursue a plan to separate BD&#8217;s Biosciences and Diagnostic Solutions business from the rest of BD to enhance strategic focus and growth-oriented investments and capital allocation for both BD and the separated business and enhance value creation for shareholders.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8220;Our BD 2025 strategy has transformed the company into a faster-growing, more profitable organization positioned at the forefront of long-term growth trends in health care, and we believe today&#8217;s announcement is an exciting next step in unlocking significant potential value for all our stakeholders,&#8221; said Tom Polen, chairman, CEO and president of BD. &#8220;We believe the separation will position New BD as a differentiated MedTech leader and enable optimized investment to accelerate our innovation pipeline and ongoing margin enhancement through BD Excellence to further fund growth. We believe Biosciences and Diagnostic Solutions is expected to deliver substantial value as a pure-play leader in life sciences and will be well-positioned to execute on its unique and compelling solutions and growth opportunities. This transaction is designed to position both businesses to thrive in our respective sectors and deliver value for shareholders.&#8221; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">The separation decision was the result of a comprehensive business portfolio evaluation launched by BD in early 2024. The company believes the separation is expected to unlock value on two fronts&#58; The creation of a New BD that is recognized as a focused, innovative and growth-oriented medical technology leader with four attractive segments aligned to both essential needs and higher-growth trends in health care, and the Biosciences and Diagnostic Solutions business that is expected to become a differentiated leader in Life Sciences Tools and Diagnostics. </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;text-decoration:underline">New BD &#8211; A pure-play MedTech innovator poised for accelerated growth</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Following the separation, New BD will be a pure-play medical technology company with leading positions in large and growing end-markets. With this profile, New BD expects to drive concentrated investments in high-impact R&#38;D and disciplined capital allocation including growth accretive M&#38;A, which positions the company to deliver differentiated and durable growth rates in MedTech. New BD will have strong, leading positions across four new operating segments in attractive end-markets with significant headroom for growth&#58; </font></div><div><font><br></font></div><div style="padding-left:38.2pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:14.33pt">Medical Essentials, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">which includes BD&#8217;s Medication Delivery Solutions and Specimen Management businesses that manufacture tens of billions of devices each year and represent the backbone of health care delivery through products such as IV catheters, PICCS, flush and other essential vascular access and management solutions, blood collection solutions, syringes and advanced needle technologies, resulting in durable, recurring revenue and strong cash generation. </font></div><div style="padding-left:38.2pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:14.33pt">Connected Care</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">, which includes BD&#8217;s Medication Management Solutions and Advanced Patient Monitoring businesses with millions of smart devices that use automation, artificial intelligence and analytics to improve the efficiency and effectiveness of patient care and creates compelling growth potential in new areas of health care such as pharmacy automation. </font></div><div style="padding-left:38.2pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:14.33pt">BioPharma Systems</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> will bring a new name and increased focus to the Pharmaceuticals Systems business unit, which is the global leader in biologic drug delivery, developing and manufacturing drug delivery devices for the pharmaceutical industry. BioPharma Systems is uniquely positioned to enable the transition to more biologics, including GLP-1&#160;treatments, and capitalize on the large growth potential of pharmaceutical industry trends, as more drug launches rely on patient self-injection.&#160; </font></div><div style="padding-left:38.2pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:14.33pt">Interventional</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">, which includes BD&#8217;s Urology &#38; Critical Care, Peripheral Intervention and Surgery businesses that advance the treatment of high-burden chronic conditions such as urinary incontinence, peripheral vascular disease, cancer and hernias &#8211; all of which are high-growth categories with attractive margin profiles and meaningful headroom for new innovation.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">The New BD will have a sharper focus on health care provider and patient end-markets. After the separation, the New BD is expected to have fiscal 2024 revenue of approximately $17.8 billion</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.82pt;font-weight:400;line-height:120%;position:relative;top:-3.67pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">, with a $70+ billion addressable market growing at approximately 5%. New BD is expected to benefit from strong, durable cash flow and a best-in-class recurring revenue profile of over 90% that will help drive focused investment, accelerate New BD&#8217;s innovation pipeline and systematically enhance growth and margin targets. Post-separation, New BD intends to focus on maintaining a strong balance sheet, making investments in innovation, returning capital to shareholders via dividend and share repurchases, and maintaining its investment grade credit rating.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;text-decoration:underline">Biosciences and Diagnostic Solutions &#8211; A differentiated pure-play leader in Life Sciences Tools and Diagnostics</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">The Biosciences and Diagnostic Solutions business is also expected to benefit from enhanced focus and investments as a pure-play Life Sciences Tools and Diagnostics leader. The business is expected to have approximately $3.4 billion in fiscal 2024 revenue with a $22+ billion addressable market growing at mid- to high-single-digits, with more than 80% recurring revenue, and approximately 30% adjusted EBITDA margins. Biosciences is a leader in immunology and cancer research solutions and related clinical diagnostics, including flow cytometry instruments and reagents, and has innovative single-cell multiomics tools. Diagnostic Solutions is a leader in microbiology and infectious disease diagnostics, including molecular diagnostics, cervical cancer screening, microbiology automation and point-of-care offerings. Both businesses have strong </font></div><div style="border-bottom:0.5pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:144pt"></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Reflects comparable FY24 revenue, adjusted for a full year of Advanced Patient Monitoring revenue generated during Edwards Lifesciences&#8217; ownership.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">leadership teams with unparalleled commercial, engineering and R&#38;D expertise, and are dedicated to bringing the next generation of high-quality innovations to researchers, clinicians and patients. The company believes that independent of BD, the business will be well-positioned to better meet the needs of research and laboratory customers and accelerate growth through more focused investment and capital allocation within the life sciences sector, potentially resulting in enhanced value for shareholders. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;text-decoration:underline">Separation Plan Overview &#38; Timeline</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">BD&#8217;s board of directors is committed to exploring all opportunities to execute the separation in a manner that maximizes shareholder value, including possible options such as a Reverse Morris Trust, sale, spin-off or other transaction. The company expects to announce more specifics on the separation plans by the end of fiscal 2025 and intends to target completion of the transaction in fiscal 2026. The completion of any separation transaction will be contingent upon various conditions and approvals, including approval by BD&#8217;s board of directors, receipt of requisite regulatory clearances and compliance with applicable U.S. Securities and Exchange Commission requirements. No assurance can be given regarding the form that a separation transaction may take or the specific terms or timing, or that a separation will in fact occur.   </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">As the company pursues this transaction, BD will remain focused on execution and continue to operate the Biosciences and Diagnostic Solutions business and the other BD businesses in alignment with its BD 2025 strategy, including continued investments in commercial growth, innovation, M&#38;A and other initiatives that are part of the company&#8217;s multi-year strategic operating plans.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">In connection with today&#8217;s announcement, the company has decided to postpone its Investor Day, previously scheduled for February 26, 2025, to allow BD to focus on the transaction. The company expects to provide a comprehensive update on strategy and outlook in the future closer to the separation.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Citi is acting as lead financial adviser, with Evercore also serving as a financial adviser. Additional advisers include Wachtell, Lipton, Rosen &#38; Katz, PricewaterhouseCoopers, Skadden, Arps, Slate Meagher &#38; Flom LLP and FGS Global.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;text-decoration:underline">Conference Call and Presentation Materials</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">BD management will host an audio webcast at 8 a.m. ET tomorrow, February 6, to discuss the separation plan in conjunction with its previously planned discussion of the company&#8217;s financial results for its first quarter of fiscal year 2025, which ended on December 31, 2024. The company has posted an accompanying presentation to the investor relations website at&#160;</font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">www.bd.com&#47;investors</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The audio webcast can be accessed through BD's website at&#160;</font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">www.bd.com&#47;investors</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The conference call will be available for replay on BD&#8217;s website, </font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">www.bd.com&#47;investors</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Alternatively, you can dial into the replay at 800-839-2486 (domestic) and 402-220-7223 (international) through the close of business on Thursday, February 13, 2025. A confirmation number is not needed to access the replay.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"># # #</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">About BD</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit </font><font style="background-color:#ffffff;color:#0000ff;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">bd.com</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> or connect with us on LinkedIn at </font><font style="background-color:#ffffff;color:#0000ff;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">www.linkedin.com&#47;company&#47;bd1&#47;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">, X (formerly Twitter) </font><font style="background-color:#ffffff;color:#0000ff;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">&#64;BDandCo</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> or Instagram </font><font style="background-color:#ffffff;color:#0000ff;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">&#64;becton_dickinson</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">This news release contains certain non-GAAP financial measures. These include revenue for New BD adjusted for a full year of Advanced Patient Monitoring revenue generated during Edwards Lifesciences&#8217; ownership and adjusted EBITDA margin on a forward-looking basis for the Biosciences and Diagnostic Solutions business. These non-GAAP financial measures are not in accordance with generally accepted accounting principles in the United States.  BD strongly encourages investors to review its consolidated financial statements and publicly filed reports in their entirety and cautions investors that the non-GAAP measures used by BD may differ from similar measures used by other companies, even when similar terms are used to identify such measures. Non-GAAP measures should not be considered replacements for, and should be read together with, the most comparable GAAP financial measures. Reconciliation of New BD revenue to the comparable GAAP measure is included in the accompanying presentation available on BD&#8217;s website, www.bd.com&#47;investors. The adjusted EBITDA margin for Biosciences and Diagnostic Solutions on a forward-looking basis excludes adjustments for potential charges or gains that may be recorded, such as, among other things, the non-cash amortization of intangibles assets, acquisition-related charges, and certain investment gains and losses. In addition, excluded from adjusted EBIDTA margin are certain costs that BD does not allocate to its organizational units, such as, among other things, foreign exchange, certain general and administrative expenses, and share based compensation expense. BD does not attempt to provide reconciliations of forward-looking adjusted EBITDA margin to the comparable GAAP measure because the impact and timing of these potential charges or gains are inherently uncertain and difficult to predict and are unavailable without unreasonable efforts. In addition, the company believes such reconciliations would imply a degree of precision and certainty that could be confusing to investors. Such items could have a material impact on GAAP measures of the Biosciences and Diagnostic Solutions business&#8217;s financial performance.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Forward-Looking Statements</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">This press release contains certain forward-looking statements (as defined under Federal securities laws) regarding BD and the contemplated separation of BD&#8217;s Biosciences and Diagnostic Solutions business, including, but not limited to, statements relating to business strategies (including business strategies of BD and the Biosciences and Diagnostic Solutions business following the contemplated separation), the anticipated benefits of the contemplated separation, including financial performance of BD and the Biosciences and Diagnostic Solutions business thereafter, and the expected timing of announcement of next steps with respect to the contemplated separation and completion of the contemplated separation. All such statements are based upon current expectations and assumptions of BD and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described, implied or projected in any forward-looking statement. With respect to such forward-looking statements, a number of factors could cause actual results to vary materially. These factors include, but are not limited to, risks relating to macroeconomic conditions and their impact on BD&#8217;s operations and healthcare spending generally, including any impact of disruptions in the global transportation networks or other aspects of BD&#8217;s supply chain on BD&#8217;s ability to source raw materials, components and energy sources needed to produce BD&#8217;s products, labor constraints or disputes, inflationary pressures, currency rate fluctuations, and increased interest rates and borrowing costs&#59; conditions in international markets, including geopolitical developments such as the evolving situations in Russia and Ukraine, the Middle East and Asia, which could adversely impact BD&#8217;s operations&#59; competitive factors including technological advances and new products or novel medical therapies introduced by competitors&#59; product efficacy or safety concerns or non-compliance with applicable regulatory requirements (such as non-compliance of BD&#8217;s products with registration requirements resulting from modifications to such products, or other factors, including with respect to BD Alaris&#8482; pumps and related </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">sets and BD Vacutainer&#8482;) resulting in product recalls, lost revenue or other actions being taken with respect to products in the field or the ability to continue selling new products to customers&#59; changes to legislation or regulations impacting the U.S. or foreign healthcare systems, changes in medical practices or in patient preferences, potential cuts or freezes in governmental research or other healthcare spending, or governmental or private measures to contain healthcare costs, such as China&#8217;s volume-based procurement tender process or changes in pricing and reimbursement policies, which could result in reduced demand for BD&#8217;s products or downward pricing pressure&#59; new or changing laws and regulations impacting BD&#8217;s business (including the imposition of tariffs, such as those relating to China, Mexico or other countries and regions in which BD does business, sanctions, changes in tax laws, new environmental laws and regulations (such as those related to climate change or materials of concern), new cybersecurity, artificial intelligence or privacy laws, or changes in laws impacting international trade or anti-corruption and bribery, or changes in reporting requirements or enforcement practices with respect to such laws&#59; the adverse impact on BD&#8217;s business or products of past, current or future information and technology system disruptions, breaches or breakdowns, including through cyberattacks, ransom attacks or cyber-intrusion, and any investigations, legal proceedings, liability, expense or reputational damage arising in connection with any such events&#59; increased labor costs and labor shortages or disputes&#59; BD&#8217;s suppliers&#8217; ability to provide products needed for BD&#8217;s operations and BD&#8217;s ability to maintain favorable supplier arrangements and relationships&#59; increases in energy costs and their effect on, among other things, the cost of producing BD&#8217;s products&#59; adverse changes in regional, national or foreign economic conditions, including any impact on BD&#8217;s ability to access credit markets and finance BD&#8217;s operations&#59; risks relating to BD&#8217;s overall indebtedness&#59; the possible impact of public health crises on BD&#8217;s business and the global healthcare system, which could decrease demand for BD&#8217;s products, disrupt BD&#8217;s operations or the operations of BD&#8217;s customers and companies within BD&#8217;s supply chain, or increase transportation costs&#59; interruptions in BD&#8217;s manufacturing or sterilization processes or those of BD&#8217;s third-party providers, including any restrictions placed on the use of ethylene oxide for sterilization&#59; pricing and market pressures&#59; difficulties inherent in product development, delays in product introductions and uncertainty of market acceptance of new products&#59; the overall timing of the replacement or remediation of the BD Alaris&#8482; Infusion System and return to market in the U.S., which may be impacted by, among other things, customer readiness, supply continuity and BD&#8217;s continued engagement with the FDA&#59; BD&#8217;s ability to achieve BD&#8217;s projected level or mix of product sales&#59; BD&#8217;s ability to successfully integrate any businesses it acquires&#59; uncertainties of litigation, investigations, subpoenas, settlements, fines, penalties and&#47;or other sanctions (as described in BD&#8217;s filings with the Securities and Exchange Commission (&#8220;SEC&#8221;))&#59; the issuance of new or revised accounting standards&#59; risks associated with the impact, timing or terms of the contemplated separation of BD&#8217;s Biosciences and Diagnostic Solutions business&#59; risks associated with the expected benefits and costs of the contemplated separation, including the risk that the expected benefits of the separation will not be realized within the anticipated time frame, in full or at all, and the risk that any conditions to the separation will not be satisfied and&#47;or that the separation will not be completed within the anticipated time frame, on the anticipated terms or at all&#59; the risk that any consents or approvals required in connection with the contemplated separation will not be received or obtained within the expected time frame, on the expected terms or at all&#59; the risk that dis-synergy costs, costs of restructuring transactions and other costs incurred in connection with the contemplated separation will exceed BD&#8217;s estimates&#59; the impact of the contemplated separation on BD&#8217;s businesses and the risk that the contemplated separation may be more difficult, time-consuming or costly than expected, including the impact on BD&#8217;s resources, systems, procedures and controls, diversion of management&#8217;s attention and the impact on relationships with customers, suppliers, employees and other business counterparties, as well as other factors discussed in BD&#8217;s filings with the SEC. There can be no assurance that the contemplated separation will in fact be completed in the manner described or at all. For a further discussion of certain factors that could cause our actual results to differ from our expectations in any forward-looking statements, see our February 5, 2025 earnings press release and our latest Annual Report on Form 10-K and other filings with the SEC. BD expressly disclaims any undertaking to update or revise any forward-looking statements set forth herein to reflect events or circumstances after the date hereof except as required by applicable laws or regulations.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Contacts&#58;<br><br></font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Media</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#58;&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Investors</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#58;</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Troy Kirkpatrick&#160;&#160;&#160;&#160;Adam Reiffe<br>VP, Public Relations&#160;&#160;&#160;&#160;Sr. Director, Investor Relations<br>858.617.2361&#160;&#160;&#160;&#160;201.847.6927         </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"><br></font><font style="background-color:#ffffff;color:#0000ff;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">troy.kirkpatrick&#64;bd.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">  &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#0000ff;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">adam.reiffe&#64;bd.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">     </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>bdx-20250205.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:a17b5a9c-6085-49b3-b1b7-4455cd2e45ff,g:5794aaff-59c8-4a79-93e5-b917e5904b6f-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bdx="http://www.bd.com/20250205" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bd.com/20250205">
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdx-20250205_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdx-20250205_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdx-20250205_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.bd.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bdx_Notes1.900dueDecember152026Member" abstract="true" name="Notes1.900dueDecember152026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bdx_Notes3.020dueMay242025Member" abstract="true" name="Notes3.020dueMay242025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bdx_Notes1.208dueJune42026Member" abstract="true" name="Notes1.208dueJune42026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bdx_Notes1213DueFebruary122036Member" abstract="true" name="Notes1213DueFebruary122036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bdx_Notes0034DueAugust132025Member" abstract="true" name="Notes0034DueAugust132025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bdx_Notes3.519DueFebruary82031Member" abstract="true" name="Notes3.519DueFebruary82031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdx_Notes3.828DueJune72032Member" abstract="true" name="Notes3.828DueJune72032Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>bdx-20250205_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:a17b5a9c-6085-49b3-b1b7-4455cd2e45ff,g:5794aaff-59c8-4a79-93e5-b917e5904b6f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.bd.com/role/CoverPage" xlink:type="simple" xlink:href="bdx-20250205.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.bd.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_b7037e8c-7eae-4b2f-8764-14bcc9b48bae" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_EntitiesTable_b7037e8c-7eae-4b2f-8764-14bcc9b48bae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a18a8123-7950-443e-9531-2953bdef33ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_b7037e8c-7eae-4b2f-8764-14bcc9b48bae" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a18a8123-7950-443e-9531-2953bdef33ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a18a8123-7950-443e-9531-2953bdef33ca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a18a8123-7950-443e-9531-2953bdef33ca" xlink:to="loc_us-gaap_ClassOfStockDomain_a18a8123-7950-443e-9531-2953bdef33ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0f1f1c4e-1387-4d9c-80d4-be96d8120f15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a18a8123-7950-443e-9531-2953bdef33ca" xlink:to="loc_us-gaap_ClassOfStockDomain_0f1f1c4e-1387-4d9c-80d4-be96d8120f15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0ec5d31a-b849-45c8-8ac8-d98675e972b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0f1f1c4e-1387-4d9c-80d4-be96d8120f15" xlink:to="loc_us-gaap_CommonStockMember_0ec5d31a-b849-45c8-8ac8-d98675e972b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.900dueDecember152026Member_3d451513-8293-43a1-865f-e6ffdbe0d683" xlink:href="bdx-20250205.xsd#bdx_Notes1.900dueDecember152026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0f1f1c4e-1387-4d9c-80d4-be96d8120f15" xlink:to="loc_bdx_Notes1.900dueDecember152026Member_3d451513-8293-43a1-865f-e6ffdbe0d683" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.020dueMay242025Member_b5448b00-e4d3-4d25-bc5a-a95665511bca" xlink:href="bdx-20250205.xsd#bdx_Notes3.020dueMay242025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0f1f1c4e-1387-4d9c-80d4-be96d8120f15" xlink:to="loc_bdx_Notes3.020dueMay242025Member_b5448b00-e4d3-4d25-bc5a-a95665511bca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.208dueJune42026Member_7f28eca6-c93f-4c90-976f-e3220effd5b9" xlink:href="bdx-20250205.xsd#bdx_Notes1.208dueJune42026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0f1f1c4e-1387-4d9c-80d4-be96d8120f15" xlink:to="loc_bdx_Notes1.208dueJune42026Member_7f28eca6-c93f-4c90-976f-e3220effd5b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1213DueFebruary122036Member_9f38fb98-7392-4280-86c3-443495414cd3" xlink:href="bdx-20250205.xsd#bdx_Notes1213DueFebruary122036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0f1f1c4e-1387-4d9c-80d4-be96d8120f15" xlink:to="loc_bdx_Notes1213DueFebruary122036Member_9f38fb98-7392-4280-86c3-443495414cd3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0034DueAugust132025Member_0313b76d-d263-4480-9935-3cac28492c55" xlink:href="bdx-20250205.xsd#bdx_Notes0034DueAugust132025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0f1f1c4e-1387-4d9c-80d4-be96d8120f15" xlink:to="loc_bdx_Notes0034DueAugust132025Member_0313b76d-d263-4480-9935-3cac28492c55" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.519DueFebruary82031Member_cad671d2-b25c-41f5-86b1-59fe306d57e5" xlink:href="bdx-20250205.xsd#bdx_Notes3.519DueFebruary82031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0f1f1c4e-1387-4d9c-80d4-be96d8120f15" xlink:to="loc_bdx_Notes3.519DueFebruary82031Member_cad671d2-b25c-41f5-86b1-59fe306d57e5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.828DueJune72032Member_185d9978-b5ee-47c1-a728-89205d8613e3" xlink:href="bdx-20250205.xsd#bdx_Notes3.828DueJune72032Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0f1f1c4e-1387-4d9c-80d4-be96d8120f15" xlink:to="loc_bdx_Notes3.828DueJune72032Member_185d9978-b5ee-47c1-a728-89205d8613e3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_84d610bd-7d46-46a8-9366-de9876f648c7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsExchangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_b7037e8c-7eae-4b2f-8764-14bcc9b48bae" xlink:to="loc_dei_EntityListingsExchangeAxis_84d610bd-7d46-46a8-9366-de9876f648c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_84d610bd-7d46-46a8-9366-de9876f648c7_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityListingsExchangeAxis_84d610bd-7d46-46a8-9366-de9876f648c7" xlink:to="loc_dei_ExchangeDomain_84d610bd-7d46-46a8-9366-de9876f648c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_f38eff30-2071-4c3d-912f-cfdbbc11ec61" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityListingsExchangeAxis_84d610bd-7d46-46a8-9366-de9876f648c7" xlink:to="loc_dei_ExchangeDomain_f38eff30-2071-4c3d-912f-cfdbbc11ec61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_7ec01e5b-458e-4403-8749-c61107a5622f" xlink:href="https://xbrl.sec.gov/exch/2024/exch-2024.xsd#exch_XNYS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_f38eff30-2071-4c3d-912f-cfdbbc11ec61" xlink:to="loc_exch_XNYS_7ec01e5b-458e-4403-8749-c61107a5622f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_79773729-3de9-422c-8d7c-3741a53bd07d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_DocumentType_79773729-3de9-422c-8d7c-3741a53bd07d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e8caffd1-cbfd-48e1-96b9-93337a7efd3d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_DocumentPeriodEndDate_e8caffd1-cbfd-48e1-96b9-93337a7efd3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a3900605-c7a0-4e24-8263-45e558857e0e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_EntityRegistrantName_a3900605-c7a0-4e24-8263-45e558857e0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_0a675f16-c432-4867-94d3-1461eb7c1213" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_EntityCentralIndexKey_0a675f16-c432-4867-94d3-1461eb7c1213" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b23f557f-118f-411d-9d72-53354ce079f5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_AmendmentFlag_b23f557f-118f-411d-9d72-53354ce079f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_f5bd842d-b1d1-47f6-8bf7-402b2b09352a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_EntityIncorporationStateCountryCode_f5bd842d-b1d1-47f6-8bf7-402b2b09352a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_1f506d70-d1fc-4f78-b902-c7c6497b2bd6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_EntityFileNumber_1f506d70-d1fc-4f78-b902-c7c6497b2bd6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_005c4ff5-8ca0-4c1b-8360-8793b66bf762" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_EntityTaxIdentificationNumber_005c4ff5-8ca0-4c1b-8360-8793b66bf762" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7bf2c2ef-45a6-412e-b58d-d68e33daf920" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_EntityAddressAddressLine1_7bf2c2ef-45a6-412e-b58d-d68e33daf920" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_5f427754-fe11-4d3b-b8a8-a982afa63742" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_EntityAddressCityOrTown_5f427754-fe11-4d3b-b8a8-a982afa63742" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_ca23c73c-8cae-4e4a-85a1-9b52c9a9d3a8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_EntityAddressStateOrProvince_ca23c73c-8cae-4e4a-85a1-9b52c9a9d3a8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7b0b220a-98d5-4b13-b346-186feb2c9dd6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_EntityAddressPostalZipCode_7b0b220a-98d5-4b13-b346-186feb2c9dd6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ed359a19-85e9-4e68-a054-e9817238c937" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_CityAreaCode_ed359a19-85e9-4e68-a054-e9817238c937" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_39ffe4a5-4b98-4f43-b69c-664637e83a55" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_LocalPhoneNumber_39ffe4a5-4b98-4f43-b69c-664637e83a55" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_088d160e-e0e4-48ac-923b-1fe3ddb34da7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_WrittenCommunications_088d160e-e0e4-48ac-923b-1fe3ddb34da7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_af95faad-3254-4e4f-b66b-b184d23deda7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_SolicitingMaterial_af95faad-3254-4e4f-b66b-b184d23deda7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_752a7932-ac9c-4997-bde0-5b7579adf644" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_PreCommencementTenderOffer_752a7932-ac9c-4997-bde0-5b7579adf644" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_298c5438-e337-4b9b-9b06-51146d283ea2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_298c5438-e337-4b9b-9b06-51146d283ea2" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1a62e8a0-b387-4b67-9fb3-1770518abe71" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_Security12bTitle_1a62e8a0-b387-4b67-9fb3-1770518abe71" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_260c04fd-99c5-43b1-9a63-3b0344566010" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_TradingSymbol_260c04fd-99c5-43b1-9a63-3b0344566010" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_751d2266-7e8c-456a-9cbb-f70859ba4648" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_SecurityExchangeName_751d2266-7e8c-456a-9cbb-f70859ba4648" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_0e190748-a2e1-4663-80f2-f43a9ff66c18" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_EntityEmergingGrowthCompany_0e190748-a2e1-4663-80f2-f43a9ff66c18" xlink:type="arc" order="21"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>bdx-20250205_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:a17b5a9c-6085-49b3-b1b7-4455cd2e45ff,g:5794aaff-59c8-4a79-93e5-b917e5904b6f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ClassOfStockDomain_50a8aba0-73a4-4eeb-8750-8e580bdf4b5e_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes1.900dueDecember152026Member_ecbcc08d-fea8-41e3-8a07-206b52d93eba_terseLabel_en-US" xlink:label="lab_bdx_Notes1.900dueDecember152026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes 1.900% due December 15, 2026</link:label>
    <link:label id="lab_bdx_Notes1.900dueDecember152026Member_label_en-US" xlink:label="lab_bdx_Notes1.900dueDecember152026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes 1.900% due December 15, 2026 [Member]</link:label>
    <link:label id="lab_bdx_Notes1.900dueDecember152026Member_documentation_en-US" xlink:label="lab_bdx_Notes1.900dueDecember152026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes 1.900% due December 15, 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.900dueDecember152026Member" xlink:href="bdx-20250205.xsd#bdx_Notes1.900dueDecember152026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes1.900dueDecember152026Member" xlink:to="lab_bdx_Notes1.900dueDecember152026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_5b95b3ca-9136-4f23-90c9-cc567bc1afc6_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_65df3104-4f27-4d22-b550-519ff06aaca6_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingsExchangeAxis_717769f5-c36c-487a-ae19-76a25a6399dc_terseLabel_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:label id="lab_dei_EntityListingsExchangeAxis_label_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsExchangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="lab_dei_EntityListingsExchangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_a6547093-8af2-456b-b5c7-e38aa1562864_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_8d51c280-88df-4396-84a6-5f03b95c2142_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_d261bb43-4543-400e-90e9-f37040d2ea66_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_b130c571-7ea0-420e-b4de-9911bdd2732d_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_0d423bed-25b9-4d67-89e1-fc2a24be7886_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes1213DueFebruary122036Member_8fc16681-f0c6-452d-8982-f724b9e16720_terseLabel_en-US" xlink:label="lab_bdx_Notes1213DueFebruary122036Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes 1.213% due February 12, 2036</link:label>
    <link:label id="lab_bdx_Notes1213DueFebruary122036Member_label_en-US" xlink:label="lab_bdx_Notes1213DueFebruary122036Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes 1.213% due February 12, 2036 [Member]</link:label>
    <link:label id="lab_bdx_Notes1213DueFebruary122036Member_documentation_en-US" xlink:label="lab_bdx_Notes1213DueFebruary122036Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes 1.213% due February 12, 2036</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1213DueFebruary122036Member" xlink:href="bdx-20250205.xsd#bdx_Notes1213DueFebruary122036Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes1213DueFebruary122036Member" xlink:to="lab_bdx_Notes1213DueFebruary122036Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes3.828DueJune72032Member_867cab0d-d45a-49c0-aed6-1982b068ba0d_terseLabel_en-US" xlink:label="lab_bdx_Notes3.828DueJune72032Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes 3.828% due June 7, 2032</link:label>
    <link:label id="lab_bdx_Notes3.828DueJune72032Member_label_en-US" xlink:label="lab_bdx_Notes3.828DueJune72032Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes 3.828% due June 7, 2032 [Member]</link:label>
    <link:label id="lab_bdx_Notes3.828DueJune72032Member_documentation_en-US" xlink:label="lab_bdx_Notes3.828DueJune72032Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes 3.828% due June 7, 2032</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.828DueJune72032Member" xlink:href="bdx-20250205.xsd#bdx_Notes3.828DueJune72032Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes3.828DueJune72032Member" xlink:to="lab_bdx_Notes3.828DueJune72032Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_f7443744-5292-4c69-85a9-2e6a6c2adb23_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes0034DueAugust132025Member_3e004986-908f-4157-a3b4-d20b8d7d5bdb_terseLabel_en-US" xlink:label="lab_bdx_Notes0034DueAugust132025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes 0.034% due August 13, 2025</link:label>
    <link:label id="lab_bdx_Notes0034DueAugust132025Member_label_en-US" xlink:label="lab_bdx_Notes0034DueAugust132025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes 0.034% due August 13, 2025 [Member]</link:label>
    <link:label id="lab_bdx_Notes0034DueAugust132025Member_documentation_en-US" xlink:label="lab_bdx_Notes0034DueAugust132025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes 0.034% due August 13, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0034DueAugust132025Member" xlink:href="bdx-20250205.xsd#bdx_Notes0034DueAugust132025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes0034DueAugust132025Member" xlink:to="lab_bdx_Notes0034DueAugust132025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_a7fd8954-4ccd-41dd-854d-da8a97e9478a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_66c509bb-1944-4c1f-bbe2-beb558305510_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_7065c7d5-dad9-4145-9f33-9eb7762e4153_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_2f810cb2-b5f4-4e83-8b6e-f0b4634b175e_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_981c1d83-0d01-464a-b247-5d6c76ec82e5_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_61ecf5e9-d4aa-4304-9e7d-b3c652f0532c_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes3.519DueFebruary82031Member_a282c40d-7ed4-4ab9-8b1d-ba58bf1336e8_terseLabel_en-US" xlink:label="lab_bdx_Notes3.519DueFebruary82031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes 3.519% due February 8, 2031</link:label>
    <link:label id="lab_bdx_Notes3.519DueFebruary82031Member_label_en-US" xlink:label="lab_bdx_Notes3.519DueFebruary82031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes 3.519% due February 8, 2031 [Member]</link:label>
    <link:label id="lab_bdx_Notes3.519DueFebruary82031Member_documentation_en-US" xlink:label="lab_bdx_Notes3.519DueFebruary82031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes 3.519% due February 8, 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.519DueFebruary82031Member" xlink:href="bdx-20250205.xsd#bdx_Notes3.519DueFebruary82031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes3.519DueFebruary82031Member" xlink:to="lab_bdx_Notes3.519DueFebruary82031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_d184927f-59b1-48d5-8370-f8d4beb3c1cb_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes1.208dueJune42026Member_57f51ec6-fe1c-4c61-ad0f-ae144c052d75_terseLabel_en-US" xlink:label="lab_bdx_Notes1.208dueJune42026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes 1.208% due June 4, 2026</link:label>
    <link:label id="lab_bdx_Notes1.208dueJune42026Member_label_en-US" xlink:label="lab_bdx_Notes1.208dueJune42026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes 1.208% due June 4, 2026 [Member]</link:label>
    <link:label id="lab_bdx_Notes1.208dueJune42026Member_documentation_en-US" xlink:label="lab_bdx_Notes1.208dueJune42026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes 1.208% due June 4, 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.208dueJune42026Member" xlink:href="bdx-20250205.xsd#bdx_Notes1.208dueJune42026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes1.208dueJune42026Member" xlink:to="lab_bdx_Notes1.208dueJune42026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_exch_XNYS_990d15f6-c402-4821-ae55-becfdb363cd9_terseLabel_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC.</link:label>
    <link:label id="lab_exch_XNYS_label_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS" xlink:href="https://xbrl.sec.gov/exch/2024/exch-2024.xsd#exch_XNYS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XNYS" xlink:to="lab_exch_XNYS" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_ee53eed7-47a3-45b2-a040-f476b6291ff5_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_7a0b5468-8547-4b5d-a46a-4f26c8bc30b4_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_fb8e133f-c892-4c1a-a761-dd6330e2f5d3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_5f9f9a41-5a88-4d29-b24a-bec2d027fb99_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_75c3269c-00a0-48c4-9f53-87338d7b5a32_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_bf40ffa6-9790-4e62-9870-23abe443a9a2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_f902b862-9117-4e7b-a7e2-18272c630370_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_4ff2f96f-0107-4f54-8256-d1a6102be267_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ExchangeDomain_46893465-2566-49df-a550-9a9cd7ad2699_terseLabel_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:label id="lab_dei_ExchangeDomain_label_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ExchangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ExchangeDomain" xlink:to="lab_dei_ExchangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_16c20c03-3fc2-4afc-9211-4f27bdd06f5d_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_5994fbdc-857b-46ff-a772-6a4dfe7c3ed7_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_b000ccf7-82d9-4709-a4e6-aeb0049a2045_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_9e7f0448-c8c1-45c6-abde-cfb8c997d443_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_bdx_Notes3.020dueMay242025Member_452103c2-8d62-4acb-8265-e8ac2249b5c6_terseLabel_en-US" xlink:label="lab_bdx_Notes3.020dueMay242025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes 3.020% due May 24, 2025</link:label>
    <link:label id="lab_bdx_Notes3.020dueMay242025Member_label_en-US" xlink:label="lab_bdx_Notes3.020dueMay242025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes 3.020% due May 24, 2025 [Member]</link:label>
    <link:label id="lab_bdx_Notes3.020dueMay242025Member_documentation_en-US" xlink:label="lab_bdx_Notes3.020dueMay242025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes 3.020% due May 24, 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.020dueMay242025Member" xlink:href="bdx-20250205.xsd#bdx_Notes3.020dueMay242025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdx_Notes3.020dueMay242025Member" xlink:to="lab_bdx_Notes3.020dueMay242025Member" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>bdx-20250205_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:a17b5a9c-6085-49b3-b1b7-4455cd2e45ff,g:5794aaff-59c8-4a79-93e5-b917e5904b6f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bd.com/role/CoverPage" xlink:type="simple" xlink:href="bdx-20250205.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.bd.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_e8393774-9c8e-4019-967b-971209904618" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_b7037e8c-7eae-4b2f-8764-14bcc9b48bae" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8393774-9c8e-4019-967b-971209904618" xlink:to="loc_dei_EntitiesTable_b7037e8c-7eae-4b2f-8764-14bcc9b48bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a18a8123-7950-443e-9531-2953bdef33ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_b7037e8c-7eae-4b2f-8764-14bcc9b48bae" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a18a8123-7950-443e-9531-2953bdef33ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0f1f1c4e-1387-4d9c-80d4-be96d8120f15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a18a8123-7950-443e-9531-2953bdef33ca" xlink:to="loc_us-gaap_ClassOfStockDomain_0f1f1c4e-1387-4d9c-80d4-be96d8120f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0ec5d31a-b849-45c8-8ac8-d98675e972b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0f1f1c4e-1387-4d9c-80d4-be96d8120f15" xlink:to="loc_us-gaap_CommonStockMember_0ec5d31a-b849-45c8-8ac8-d98675e972b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.900dueDecember152026Member_3d451513-8293-43a1-865f-e6ffdbe0d683" xlink:href="bdx-20250205.xsd#bdx_Notes1.900dueDecember152026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0f1f1c4e-1387-4d9c-80d4-be96d8120f15" xlink:to="loc_bdx_Notes1.900dueDecember152026Member_3d451513-8293-43a1-865f-e6ffdbe0d683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.020dueMay242025Member_b5448b00-e4d3-4d25-bc5a-a95665511bca" xlink:href="bdx-20250205.xsd#bdx_Notes3.020dueMay242025Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0f1f1c4e-1387-4d9c-80d4-be96d8120f15" xlink:to="loc_bdx_Notes3.020dueMay242025Member_b5448b00-e4d3-4d25-bc5a-a95665511bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1.208dueJune42026Member_7f28eca6-c93f-4c90-976f-e3220effd5b9" xlink:href="bdx-20250205.xsd#bdx_Notes1.208dueJune42026Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0f1f1c4e-1387-4d9c-80d4-be96d8120f15" xlink:to="loc_bdx_Notes1.208dueJune42026Member_7f28eca6-c93f-4c90-976f-e3220effd5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes1213DueFebruary122036Member_9f38fb98-7392-4280-86c3-443495414cd3" xlink:href="bdx-20250205.xsd#bdx_Notes1213DueFebruary122036Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0f1f1c4e-1387-4d9c-80d4-be96d8120f15" xlink:to="loc_bdx_Notes1213DueFebruary122036Member_9f38fb98-7392-4280-86c3-443495414cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes0034DueAugust132025Member_0313b76d-d263-4480-9935-3cac28492c55" xlink:href="bdx-20250205.xsd#bdx_Notes0034DueAugust132025Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0f1f1c4e-1387-4d9c-80d4-be96d8120f15" xlink:to="loc_bdx_Notes0034DueAugust132025Member_0313b76d-d263-4480-9935-3cac28492c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.519DueFebruary82031Member_cad671d2-b25c-41f5-86b1-59fe306d57e5" xlink:href="bdx-20250205.xsd#bdx_Notes3.519DueFebruary82031Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0f1f1c4e-1387-4d9c-80d4-be96d8120f15" xlink:to="loc_bdx_Notes3.519DueFebruary82031Member_cad671d2-b25c-41f5-86b1-59fe306d57e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdx_Notes3.828DueJune72032Member_185d9978-b5ee-47c1-a728-89205d8613e3" xlink:href="bdx-20250205.xsd#bdx_Notes3.828DueJune72032Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0f1f1c4e-1387-4d9c-80d4-be96d8120f15" xlink:to="loc_bdx_Notes3.828DueJune72032Member_185d9978-b5ee-47c1-a728-89205d8613e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_84d610bd-7d46-46a8-9366-de9876f648c7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsExchangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_b7037e8c-7eae-4b2f-8764-14bcc9b48bae" xlink:to="loc_dei_EntityListingsExchangeAxis_84d610bd-7d46-46a8-9366-de9876f648c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_f38eff30-2071-4c3d-912f-cfdbbc11ec61" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ExchangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsExchangeAxis_84d610bd-7d46-46a8-9366-de9876f648c7" xlink:to="loc_dei_ExchangeDomain_f38eff30-2071-4c3d-912f-cfdbbc11ec61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_7ec01e5b-458e-4403-8749-c61107a5622f" xlink:href="https://xbrl.sec.gov/exch/2024/exch-2024.xsd#exch_XNYS"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_f38eff30-2071-4c3d-912f-cfdbbc11ec61" xlink:to="loc_exch_XNYS_7ec01e5b-458e-4403-8749-c61107a5622f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_b7037e8c-7eae-4b2f-8764-14bcc9b48bae" xlink:to="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_79773729-3de9-422c-8d7c-3741a53bd07d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_DocumentType_79773729-3de9-422c-8d7c-3741a53bd07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e8caffd1-cbfd-48e1-96b9-93337a7efd3d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_DocumentPeriodEndDate_e8caffd1-cbfd-48e1-96b9-93337a7efd3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a3900605-c7a0-4e24-8263-45e558857e0e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_EntityRegistrantName_a3900605-c7a0-4e24-8263-45e558857e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_0a675f16-c432-4867-94d3-1461eb7c1213" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_EntityCentralIndexKey_0a675f16-c432-4867-94d3-1461eb7c1213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b23f557f-118f-411d-9d72-53354ce079f5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_AmendmentFlag_b23f557f-118f-411d-9d72-53354ce079f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_f5bd842d-b1d1-47f6-8bf7-402b2b09352a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_EntityIncorporationStateCountryCode_f5bd842d-b1d1-47f6-8bf7-402b2b09352a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_1f506d70-d1fc-4f78-b902-c7c6497b2bd6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_EntityFileNumber_1f506d70-d1fc-4f78-b902-c7c6497b2bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_005c4ff5-8ca0-4c1b-8360-8793b66bf762" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_EntityTaxIdentificationNumber_005c4ff5-8ca0-4c1b-8360-8793b66bf762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7bf2c2ef-45a6-412e-b58d-d68e33daf920" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_EntityAddressAddressLine1_7bf2c2ef-45a6-412e-b58d-d68e33daf920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_5f427754-fe11-4d3b-b8a8-a982afa63742" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_EntityAddressCityOrTown_5f427754-fe11-4d3b-b8a8-a982afa63742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_ca23c73c-8cae-4e4a-85a1-9b52c9a9d3a8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_EntityAddressStateOrProvince_ca23c73c-8cae-4e4a-85a1-9b52c9a9d3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7b0b220a-98d5-4b13-b346-186feb2c9dd6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_EntityAddressPostalZipCode_7b0b220a-98d5-4b13-b346-186feb2c9dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ed359a19-85e9-4e68-a054-e9817238c937" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_CityAreaCode_ed359a19-85e9-4e68-a054-e9817238c937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_39ffe4a5-4b98-4f43-b69c-664637e83a55" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_LocalPhoneNumber_39ffe4a5-4b98-4f43-b69c-664637e83a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_088d160e-e0e4-48ac-923b-1fe3ddb34da7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_WrittenCommunications_088d160e-e0e4-48ac-923b-1fe3ddb34da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_af95faad-3254-4e4f-b66b-b184d23deda7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_SolicitingMaterial_af95faad-3254-4e4f-b66b-b184d23deda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_752a7932-ac9c-4997-bde0-5b7579adf644" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_PreCommencementTenderOffer_752a7932-ac9c-4997-bde0-5b7579adf644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_298c5438-e337-4b9b-9b06-51146d283ea2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_298c5438-e337-4b9b-9b06-51146d283ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1a62e8a0-b387-4b67-9fb3-1770518abe71" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_Security12bTitle_1a62e8a0-b387-4b67-9fb3-1770518abe71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_260c04fd-99c5-43b1-9a63-3b0344566010" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_TradingSymbol_260c04fd-99c5-43b1-9a63-3b0344566010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_751d2266-7e8c-456a-9cbb-f70859ba4648" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_SecurityExchangeName_751d2266-7e8c-456a-9cbb-f70859ba4648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_0e190748-a2e1-4663-80f2-f43a9ff66c18" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3f916e9b-10c0-4711-8a93-5388f0ee66a6" xlink:to="loc_dei_EntityEmergingGrowthCompany_0e190748-a2e1-4663-80f2-f43a9ff66c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image.jpg
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MX'6J%Z/US@$Y$!E@DFL%)E[D[0ZF=V32N5(Z1G4LB=:C,UET4X!)01K P+E
MC2D@I[9WJT,$$GYH-.8*8].7@48(>#Y48%)578L[G]4(/(NUB^.55;Y!N;G
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M=4$$!0; L=3HO6.LN+27#;>-L-;EU!V[(D, O.S-87Y<JJ,#%J>+TJW,:L\
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7@?\'WB[X[QMD%>L     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_0.jpg
MB5!.1PT*&@H    -24A$4@  !9H   )0" 8    '1-&N    "7!(67,  $SE
M  !,Y0%USO"5  !S.TE$051XVNS=6^S7<QS'\1C&!2ZX,!LVXP8;+A@NG&>.
MF^-PX; QXT9JBICS(5D.)53(66K8RC&AI)SE4"D*(26I]$_JWS__E^_G]ZEI
M1A=^:\T\'NO;K__O^_U\?__?K[OGWOO\>@0      -K0PT<      $ [A&8
M     -HB- ,     T!:A&0    " M@C-      "T16@&     * M0C,
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MAC%1'M0O'P&I=;VS.>XNZ'2_5[78%+C]H>/K*075)+F7#O-%1$1$BMQ_ 0
M___LG0=TE-7VQ1_J WVHJ& 7V],GBKW[U*=_R_(ISPK2E*8B(KTCO??>NR"]
M%^D0.H1>@I#>>YGT9#*3LO_?OB<180%)D,1DYOS6NLNU()G,=^[Y/IQ]=_8!
M%$51%,75^)N60%&4(I&79ZU<P)D)9"8!,6<!K[6 QTC@Y[I _X> SO\ .OP=
MZ%@)&/L:L+P5L',T<'0A<-KZVI7M@&%/ ]UO!3I=#[3]FYNM"E*;+C<!<^H
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M&!MU&O!: ZSI(@,!RU,-V&MT"/-P@]G;00> Q% Y ,%%PB/-U#6GM?^9<M!
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M^+"G94#@H;E ^+%SSF;]=.Z2 C.C 6RI.5BV-P4MI\3@]2[!N+^9OPI;+B9
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M]W$B.D])P<>+G)B].0=;CA;"FNQ&>FX%2LL4-*M4*I5*I:!9I5+YKPAF&4O
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M/E;MR4=8I,N\7&!&-T$TW]/#EF:87V=XD=1]>BK>F)B,MJ,=>'Y8DADG\<0
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MOE'@CGD&F/,^L&V,B#7*M(+,,N%<ZAF)=M&7YA)AEYL$)(>*9#N\0,3WFE[
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MN]XH15$41?$"*IH5Q>._7;ND@_+X,NG^'?M<X(OF7R(UK@)ZWB3">7(#8.-
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M19 .@M++G#G3>^_M3#GSYEO?@LNMB8_G(^?,L-[GV?\H#&?.M_>>,^]>^[?
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MHF,\?QZ20I\YV2S:5LR!^  )6=44E@6IJ I24UL_C;.)9B-49/YG%M1P-#G
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MP+K!L'N&BB$1R](P+/.XQF*(<*HH4AD9M"[8#6M^!$_$J^2K6)9F<2(&D_9
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M-V8BM\"%0H?;?(V*HBB*HG@&%<V*XO%OKL:WUN1@X.1*X,!,X. LXYH-'%D
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M>5I"OS%?*"J:JQZ482E9Q0B**L3XU1EX9U@"'F\?B9O?MTZHELZ#JYN&H,'
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MGYC"PBWY]EL(BJ(HBJ(XBXIF17$*$70BF^._AW6#8-P]I@*X;QWO2+$^%\/
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M?J226:KZ5W]7:.<R/]8_CML[1U._E?N1&2*Y90.FP6N1=J7_Y-4Y=C9S:FZ
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MH.\M IO5U2PU^46K[R.L.=PCSN,B9_G,-X$U,X@YW[RNTU^U>G^K[_;^D]>
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M=&DW'F,WG^F-1QP&T&<X*G;N52J52J52*6A6J:J.3'"?!W 5 "=62K3#V">
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MC-6@(WQ]+V#.OP6Z#ZPM\1LZ8^<NNKN'W"- GH<5["7GZT+YURH%S5H^$2%
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M      !2A&8      %*$9@      4H1F      !2A&8      %*$9@
M4H1F      !2A&8      %*$9@      4H1F      !2A&8      %*$9@
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M71?+MU2K?WU4J^NH06W/:)0ZH^X86TW-_0-(6EM-O?)]U!V AOL 3GVLZP&
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ME GE(!8FJ-OY?L;]T2/3.]CG<,\DFK#A88S1?W\Z+$V\:VDO_I_W,J9XT=;
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MGUP/;V&V72_84"5;PX$(%O989?,IXXW= DICX%IW"NE8@FW^*?D&! ,>@=O
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M8VD X$()U1?0S/\"!P&*>+URX. /?>#:>,0FJ;]-SA%HS]9L<\!B;&7*+3,
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MM>R-@/H@J:%/REA_ *WP<>4 *\";WS^6[:_ 2Q22V#3@:=P7SV0 #!ZX*(F
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MVK$U/AGM"VQ>OZU1KGFD0H$EYSWX],YKXOP\C^%WE,A,;8]ZM6TH4U"P=TC
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MF4PFDRE-";=B))L9D,<BB6S-_<G<3670 FF!C"SN'W"+*Q;#H4A" 5)W$N
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M#LY1/\1[I_\M<L*$8KGYR5H-#F271[4/F$RFGBD#S2:3R60RF4QI8FL_BVX
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M9S0_\5I(M]4#EOT2/!D'S>X9*1F2:=!<4!53.]+^F0+-L79O1PB9XY2D(4C
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MXRDH1?U.8#+W2[^@?W ?E *@IFSP<P#&KI 'Y45A,T$&H!09CX!P2G\0!
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M&;1A\MUS:G7_2W6V5_/(A8V:]&&39BUOT8(-;5JY*Z[MAQ+Z*Y11+.%RXS\
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MF#;7O>(:-->^[JQ;V&/%Z^.I.C>SO\T<NK.>G9.YMIM]EBC,-9UECZ%/_0T
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MH ?S"61LJTQZJUFN'^66:X<XY2_OK)&+;[%$[)=[UTJ?R5Z5S"A]@8CE/^1
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M&L!G<DOJ9-WI:/-U!VBF7_+<+_2\P!KM_X["]<C*8O4_MZ6K_[XT7@VX)$Y
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MTY[-4U?K\@ <A]R?I<N2J=LJ2]J(/VT;C7PTH"8_G:?^]4*!FKNN5$  @(U
M!G555V^ ]M<--)M 0X/*+@Q+>0'*C.&[GB]4X^?DJE&/4G>F+U!W%TK=F8OZ
M&Z1_3KV.T&T[]HF P!KZV7P]#ZW_J$* 'C"OHI/M3=T'!%#5RESRA![;0"=[
M39R7I_[Q0+9D,Q\S.KE9NQP^+%&=K?OAL/_D2%EN7UK0[+/M78R;C7INH9^3
M85I;M__:-%;0S'A@7.<6UZG/TFJD'$ NYA[&]R1=9Z-FZ[E+U]O@^\S8OL@;
M#[9-^3GU!EB<]DR^^H^>][C'YMT5>CZOE?%>5Z]Z+;N6,070 PBRUA#H>/"5
M(G7SHGPUYO& ]+^ANA^:N=C,P_Q)V2C+93--'Z7L=^HZH'U?UVL$T)GYDO+T
MAE77FBQRYDI@Y)+->DU94:1N6D@Y<M7PAW/T>,J6][Y0UI2FM80YC/%(G[_[
MQ4*]KI?(N@Y(SM-U0YLS#])?]Z16RSQ(/1&(X?O _2^;?@UL#U76=SB[NSM
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M$A"'GXPW(" P#0>;.J.? *%PL"E+_Q:@&4AURZ("D4KX/*-6ZFI_@6;Z$GT
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M((7C3"89&8[($-REG><+='\Y?0+PW&2$4H:6D,9>P&/@%=K4  7_=O/>!LV
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MO/%-FQ(@Y/>-W)*1'6#.9D<*]<;\9$&^/P,321IVL2#1@S0*4@S=T4>9\CC
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M 0$RPJ;,SQ/HL%'7"0<LR<%^%?4"M #7U#$_(]/_C5WFT,=Q3P8D2Q?@>KA
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M[DD6G5KFJ+6[*@3\^3_;W@74*VX<VVJ_9A*V!YIMYB5U3/8J&;-DW2/C0YT
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MT!SQ@AFT$_,C\S'/M]>R]T("R_U9V#R']8M=2DA.2,#+]YGVKK;Z0RR@V7\
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M70X@(<$9(!+0%BUDZJVADW7'Q\@ZII^SU?VYMX-JVK/YTI_]V94$/ BR(!^
MWC99T&;,QO:\;SIH1NN7^>-*W?>08$ [GBQOQDPLT@&M&?V H -CB:Q99 ((
M#AS?(NN2,3%Q7JX$%@BBQ;(#@]\%8C(G $"1K0"L,:^SCC#6F8M9S^:L+6W4
MW@5F1]K87='1>9)L4F28D,E@_#(VD$< \I$-3]^\\_E"T;2.MF99^1&R;CGT
M[<I9 ='TM]).=FUDC2*PN71S4, \!TU6AR.=;B, M<Q3>LUCW6>>0N;IA+$I
M#C3'8*V!Y@,&F>\O!-'/FYXA_81V(UL]SI/'H Z[\GV&0 OCBS[-X8'L,B+H
M0;TV[1J(EW%!4"33RWSO3!#5F3-G;9L#S<Z<.7/FS)DS9VW")>-XHN7'@4<F
M,\;"7R,%@3,-^&'+;:P''5D(QP7,N&U)OAPVA=ZD!7\<F&,/I++0V<)FMIL"
MJ#N3,6F?RX&"9.("-]CB#!3 *0,JG7]7IFRK)INR/:/<E)_MNE.?R1,@X'?&
M>5>D1\9KY_F5K65=UI5NS3+RPY)U"#3'N3S<.YC-GCK/057GWFR<6^0V.NK,
M1@/-IT],51/FY*K%;QEH4]%-SGM/@&:K=\W6<@[I8_LP8-2 " ,CJ#>R]*DG
M-%'1G^UN0W: S.8;/=!&%G!?!\VT!]('!!+H8_1QT=8=9#+E@$5D&5^L^]ZB
M3<%&+?#NS)0#HJ&;^L([00&%-F/4RK< $[]W1:(:/R=/O:O[1,@[5#,6^Z:#
M9NH4R8'9JTLD>(6^<G<;4(N@W((W2T6:B(SCEA(E!#)FK2P2'6BR;#L^MNI%
M%WZQ[H-D #.G-VE/FWMSX"!PE#,!6#>Z0\J$6W OM*KGK2\Q>N)ZKB3(R+K%
MFL(X9TPCPU-;IQJE$-I:>YE+ ;@$.\^<E"J TD)3*S-"L(IZ1/L9'?SNDD*0
MPSZ]H!B9S<B,6/D,!YJC6VN@F2 .946W^YK' NIU_8YR2*.NCYZ0TZ&?C=7C
MBS6:<> /S!%LH=T(R'%(;U^39W+F[*MN#C0[<^;,F3-GSIRU858O=6="E60I
MXIR0'2:P>5"\.$XXAC@S9.7DEM;%[+QQ?YP<M@>SM?C(JY+DGCBU.(F  ;)O
MCKTZ63*-K;XA0)#?!X;DRN%B'7>4(IX^9;4G P#L^)'ON61JDS$Y6CN#+VP)
M2<9P>P;DW"@PMD#D!'CG1MF/@7&2H3WF\8 <_$?66:@' !59:$ R=*[9[G["
MF&0!$90'"'>X=T ;!VWQ.^9PJ.@@,!IHIFUN7VHR6.,R:SJ]9;NE=3=HCOBT
MD^FK!B2FZWYE9$:H)[(/3QR;(OT9V0>"'\";[C:R+C]),3K'9&ZB!=W703-0
ME7?F?2;,S94M_'X]:_K;!7=EJML6%\BV>]JC/9#6&;.'L $?:;^?ZOF(L7J0
M-R\<Z.DU<R@;AZ$!Q0N"L05UONF@F<QTY"8(FNW+K.V1H!AS/G/%FAUE KN8
M:YOODD@260VV_O,[L;P#.UP8NQPXB)ZQW2W0S],/YV?H\2-5  R,=)-FMI6Z
M8%[E $O&-1G,R"\U9?PGROJP=+,YTP#@VE: E/\#'C/W<@ @AS(28&6>&N =
M*DOF.5(R:W:42S_G(,WN"NS01D![^LH"O6XA]?-C62,3F\%F!YI;M]9 ,^_!
M]XR?C4]54W7_Y+L+=0'4[PG0S'<J#@8DF(ENOK_=^(Y"@@"_0S^+9=> ,V?.
MHIL#S<Z<.7/FS)DS9^TXSUQD#3_P2J%VG-,%-OME&7"@AWE@PLHFQ')_(!H9
M:V_L+)<LM@,'-V4IXI3]:7J&&CD[(*#1.J0&&L1+QAK@ZXL8@4@D8B!S:7F]
M..F %?]!46CG#KH'Z01SF%DTO6&<-.0$_O%@MART8P\RM-N; 58/K2B23%JD
M2&K"W>]56OU3'',RX#B0"AA/^QAM2--6P,"%&X.2 4V]1\N BP::_W!KAGID
M9;'Z.+E*91>%NVT+;G>#9B 0]RRKJA?(=.G,)GD39%EH?S(&J3?J#U! _?1$
M6W$('7T*'=G'5Y<(\.[KH)DM_&_LJA Y$3+FCQG=O!^<K=OGAOEYZOFW0Z)I
M3B"GN^&)/82->0;-V@L\Z9'O^.8%QAL9Z61=$_P!:,5BWW30#,P<^T1 O?M9
MA1R,UQ-]CW;,*3+Z_T^N*1'IG98[0/YT6X::.,?L ,F/(5A WYNIQ^]?;C<'
M?!X\M$FK'M XZM$<M?*#,JF#KNK(MV; 5N:CQU87R_AEGC+:UT:?]X]ZOISU
M6I&\)VM!6_,E]0,$G+NN5'1\F:OL&0F4"<A,5C_ZV03$PO7V@,WN:2]N8P\\
M9/Y'GN,7D]/442.3)3#G0'/[UAIHIMT(]C+?HT&.+(P]3+8G#*DAQM=(W>?1
M)#]@4%.[\1WG6EW'*[>7J]VI1M?;F3-GW6<.-#MSYLR9,V?.G$4Q,E[8G@O8
M RCY-67)+B;[#&UB'.R,&+9: _]P]G%2E[X=$H!EMI@:\(>3/O+1@!S(AI8N
MV8O^S#NRPWCNNS$_U^@8(HN P\G[^[>5DJW)UE:;@<S6UM:!B8&7:"OR'G^X
M-5TRLJV^--F59!*;++:@RM._![BM[P'_%C!@MV[SWI0)S6D.F_-#'+('J4]D
M+M!GC :&HX%F@@_(4"!I@+1"N(^"9MX+<):B[SEG;;$Z;WIZ8U##'C()F!IT
M3[: > (7P-*>@ #T>P-Q(FJQ[A=D/O9UT,SX6OB6T68FB]UJ,UN QA9^V@+]
MV<R".BEC3UEF85@"6Y/FY4J&JG]>X.)0SRGS\V7,[4FKB>G>#C3'JPES\]3.
MQ"H!<3VAW6KGWU0]_])&%]V=]:7^?\Z-Z;+[XOFW@S*OM#_W>3M4PF9G#'KQ
M)^NV.F)XHF3_RF&LER?*SVY;4B  CN?'<LA@1XT )GV. RG)&$6:QU^V7^M_
MDZG-G J,;.L=.!QWV;LAT;%&S]??1OR=LPR0M$""IR?D??S&F)ZNZXU#. &E
M!SK0'-5: \U\'R"3^(]ZOB>8N3?&N2E68R[CW(0;%N2I<V]*;USKN) Y&C4[
M(/K?2,WTQ,X%9\Z^R>9 LS-GSIPY<^;,632P4\"!@"'M;.8+4#IB>!/8(;N)
MK./;EQ:H%>^7B8/540/4IN>%U=;/*]6LUXI%.]-F;'UO6((X9!Q&1+8S,AG'
MC$YJM@V5YZ+K_/*V4$S/)8N( ]ZVQU=+-BZPR@\#.& )C5X.C /*5+8ARP$,
M!5C$9=;*>_Y\8JHXE@,\@ D 0Q9AG':F*4.%!VYZ@L%9_6&V;@,?)C^=+_73
M,O.40Q2!%\ R'-%H$//K IH!.@1,MNRM5#->*)2 R0$^Z0<.-?SS[9EJROP\
MM6I[F92[(:)ZJ*T\61K=#Y]_)R3MU-=!,S"+PSI_>V.:9,-))OB@> DT,5[_
M^9\<D0Q@K@# ]B!G%CF3+9]5J#EK2V17PW%7)WWI,+G+'\R1@,JV?94Q97DZ
MT-SSH)GF8"XD*$:?&7Q?<]!,$(,,3#)V%[T5E$!>1^Y7I.^WZL-RZ1,$V ![
M1A\Y421Q +9D #,/5'7A4,/VC/IBK "\[UU6*'"VF:;]I%2I7PZU!'BWI6E/
MEBGO>NG,;'7FY#0IB[T'P<OA#^?([@'NP6Z#GK3M<56RDX%U\J2Q#C1WQ/H"
M:$9CFXSENYXOE+Y/0+"IW9)EG,Q_LU36S_Q@G7+FS%GWF0/-SIPY<^;,F3-G
M40Q'E@,!YZTK$:"$/F33 3?QDK5U]6,!-5?_/]M!.VHX^I^GUZ@5VT+JUD4%
MZIP;TP1>(6% Q@U.-H<Z)637R%93,D[M]N$!WG-'SLZ1 _MB>2Z #SD0G%$R
MW,B>\VLJ\QY -: 3!^5PV&!KAJ.:55@G6<]H+AXSRG_P5+QVR@W<N%,[>F2%
M]8955)NLOEDKBZ6MR&KV@P[THFU;\4[1G.VO"VA&WH0L;C(D.;R00R>;W6]\
MJCC>W(]#PGHBV[$U0T^V9:"C+X%FHSVKI'T)ZB!KP.&<2+&8 _CB!7RAV\PX
M"/?@5G!_6\9EU:BW/JU0TY[-DQT(_OH#A),E3D8I?3<6Z.U <V^ 9A-D8<RN
M_[A"I"'\]0PD1H*(G2#SWRP129[V3#*DRQM4JIXO6"_^=T9FL_L1&#U[6KK,
M%\^QLZ0'P2R9U8!Q^A&R!>>U""*=HOLJD!B(S#S=EEX_8^F61?GJ-U/3)0@&
MW)4=!'I]//+*1'7]_#R9OUF?F/-[TG8D5*E[EA6*5 VZZ(!;!YK;M[X F@EX
M;-#CZ\$51=)V?M#,=S@".4@W;=Y3&777@#-GSF(S!YJ=.7/FS)DS9\XZX!@"
MA-$K!B@!<JS#0E8H /C"NS,%!@/I.FK !K*E<,A'SPZH,R:EROW(7.:4>PY4
M6KVC7.44A\4Q/WMJFOJ.YSCB-)VLGXL#A9;RUGV5'7XN$)/MHO/6EZHQVM$]
M<W)J([S&&43C%?D)G'A@4EN9;\7E]>(LD@&+KBD0SI]QC8XF4 %G[I,80'A7
M#$#*H6T<8L@A4F=-:0[+<'2'WI\E\!8-VV@'$WY=0#-]>//N"O7P:\6BR7W2
MV.;E(&A!L !)!B!B3V@SMV9]'30;[>]Z&:?T)R @?;N_Z+,G2)\_?6*JR '0
MQXU.;,^^$Q()S GTN7N7%<F\X3^8\,@KD]29^F<$5!B;#C0WM_T-FC&3T:]D
M#@)XM03-!(*04B+C,KNH?0C&_(Q<RX<)U1)@.Z_%>.)P0> S0476DY[09FXJ
MEQ(9@L2<6C5__9?UIT]H,?^V[$,-#>8>FW=7"H3]R=7)4A]R".#@> &7K'MD
MJ;(F\_F>:B-K#C3';GT!-',& &L>N\7H_RU!,P$>UD\YR-F!9F?.NM4<:';F
MS)DS9\Z<.8MBP$NRM/9JQQ:G$D?7.BP )V 36YW'S\D3N8F.&@[R6Y]6JCN6
M%J@+9V1)!C#.$! 1)Q%G?-L759+!"/C]VYT9ZJA19%0:T(4>\AF3T]1U<W(%
MAL8"JC9I1_[NEPHE:XX3V:VF,MNVA]Z?+3(@P,;V#C6C3H"<3Z\O$7@)(/0#
M&[(J;WPV3V!B7&9-K[05=9H<"*NW]U2*G$=+6 88 'Y,>R9?K=I>'O40H*\+
M: 8N 1UQ_@DDM)04X5!##A$C<Q_MV'"= \T8,(9VI0]<\WA ]VMS>"+CA<QF
MI&&H3P ??2#2"Z\*B*.]Z;M/O5$JFM%^&11@%5F@Z+HO?R_D0',+ZPN@V1XT
MRSPU[*&<9O4,$$3^!)WYI]='!\WF@,A:M5JWR_2E33M4[,5ZQ5AZ<HV9*WJR
MW0#H@-0L_<Z+-Y6J"^YJ/K;9J7/AC$S1/$9.":DC?YW8 R_?V%FA+IN9+6L2
M\C1&4BI!_4#/#;_6_9WQQF&"<IA<@P/-+<V!9B7R8*QGC'5TT%N"9OH7 7QV
MACC0[,Q9]YH#S<Z<.7/FS)DS9U$,YQ'8B\./@_NK&U(%2 P8;!VX1'6L=J#)
M3 /0XBCC,+<'>/@_#DY"3WC,XP&!10!KLHK1S^5$=++9=J=6"Q@&&"%M0/8B
M6Z'[#31.Z5&CFI[+[X4[H($,I,(1!5#_7CNUP&M U1':B3_UNE315 :81[L/
M>K1K=U6HF:\4J8O_G2F0VCIR.)AD$0$OR00'FO966^44UZD]J37B8+;4_R7;
M$Q!S]>R '#85+;OOZP*:T:!\<4M(,N=_=U.ZU(/_?L#W>>M*I1QYI?4]<F!C
M:];703/] ]C#X69(L?CU61GWC%M^/G]]J6C?]H8U CG=1SB@D(".:*-[(.6@
M(?&2!?H7W:9+-@4;85Q'M)H=:.X=T&SMG;V5TG]:@N;3)J2HBSH(FIDK/DJJ
M%MD,9''82=(2-#-7/+:Z1*W962[E9^[NB0NX!_1&.WEV*_/OT5Z@;^J"O"\%
M^NBCC'5^QGH''+1241;",O^>?U>FR%@5!'OG #<'FF.WO@":.<"5M?%QW0\)
MVGP)-#^0K1Y9269]N>S><N;,6?>9 \W.G#ESYLR9,V=1C(0I@ -@!?A+!B/9
MQ(=<A@,7+XX<#N+Y=V9HYS"H0E4- GT;HH!F#ME;JAT^G""V"!]V>:* +  1
M![:1@8JC"4A8MZM<W:0=-YQTLL)P'/E=LBK_IAUO#HWB,"B<QVB0$(>8PYB&
MW)\MLA\</(CF[ ECS(%P9%AW1 ($9QFIA9L7Y<L[X\A:1X[W&G)?EIJ[MD3N
M1?99;QAE+REO$$C[[,:@U(T?=!P^+%$.I")K&S 3[;3YKPMHYMT6ZOJ@W 0K
MJ ?__8 Z+[X;$DAO#P+L#>OKH#E04B_:UL]L,.-E@ ]6$%@!I"%Q@U1+;P53
M ,9 .;)'7]@2E+8[8D1B(]0!J"#K04 !^8)J[^"WJ)SY_P,  /__"V_BC@
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M 30WS]'N2* Y?*V DX=>R==^"[ );Z9).^?/0Y[+UE4#)17U.A'4GB*;ELD
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M@&M7K)[R-C#T)K9I#ZQ:X3W(=82S\H^V##2;3-U;!II-)I/)9#*9CD 4MGL
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M?ZL_M#&4!QI.'^C3',_-[IIQ<+$D_T@$1 "&[$JJ43#"DEW. <#AG!28.*L
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M8V;6R9-OM&NV4K8%("43BH/JE&>:79LJY.#SBA1R P2"[&I@W%==>P ]P -
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M,.I'EY9J]B,V!'#8'-"DSU%0-YBY!+J0'7C8A25ZC9V,=H( MRYLU$ '968
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MB.,%0P!@ZM-2ZY.2 6?=5:,'7Z[N C/),MK'KY<)Q-@][; +S !DD!'%BZL
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M9*#99#*93*:MT_\!  #__^S8H0T , S L/W_=(>+PRK[A,#,     ,N3
M  " PF@&     " QF@$     2(QF       2HQD     @,1H!@     @,9H!
M     $B,9@      $J,9     (#$: 8     (#&: 0    !(C&8      !*C
M&0    " Q&@&     " QF@$     2(QF       2HQD     @,1H!@     @
M,9H!     $B,9@      $J,9     (#$: 8     (#&:X8@/  #__^W8(0$
M  C ,/J7AA 7F"W"Y7<!    X,=(      ! 830#     ) 8S0      )$8S
M      ")T0P     0&(T P    "0&,T      "1&,P      B=$,     $!B
M- ,     D!C-       D1C,      (G1#     ! 8C0#     ) 8S0
M)$8S      ")T0P     0&(T P    "0&,T      "1&,P      R0&;^$_$
0Z^D$NP    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45448830007296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Feb. 05, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb.  05,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BECTON, DICKINSON AND COMPANY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000010795<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-4802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">22-0760120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1 Becton Drive,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Franklin Lakes,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07417-1880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(201)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">847-6800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $1.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.900dueDecember152026Member', window );">Notes 1.900% due December 15, 2026 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.900% Notes due December 15, 2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes3.020dueMay242025Member', window );">Notes 3.020% due May 24, 2025 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.020% Notes due May 24, 2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.208dueJune42026Member', window );">Notes 1.208% due June 4, 2026 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.208% Notes due June 4, 2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX/26A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1213DueFebruary122036Member', window );">Notes 1.213% due February 12, 2036 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.213% Notes due February 12, 2036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX/36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes0034DueAugust132025Member', window );">Notes 0.034% due August 13, 2025 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.034% Notes due August 13, 2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX25A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes3.519DueFebruary82031Member', window );">Notes 3.519% due February 8, 2031 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.519% Notes due February 8, 2031<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bdx_Notes3.828DueJune72032Member', window );">Notes 3.828% due June 7, 2032 | NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.828% Notes due June 7, 2032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDX32A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XNYS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XNYS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.900dueDecember152026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes1.900dueDecember152026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes3.020dueMay242025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes3.020dueMay242025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1.208dueJune42026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes1.208dueJune42026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes1213DueFebruary122036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes1213DueFebruary122036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes0034DueAugust132025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes0034DueAugust132025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes3.519DueFebruary82031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes3.519DueFebruary82031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bdx_Notes3.828DueJune72032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bdx_Notes3.828DueJune72032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MSA(>,#*5W+LG_Y#Q\ OY=G-[1:9W-X,K,OPZ^-@??Q@>D=%XT*PT>HB[ JJ
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MIR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%
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M              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @
M#81%6F'N<3;N    *P(  !$              ( !KP   &1O8U!R;W!S+V-O
M<F4N>&UL4$L! A0#%     @ #81%6IE<G",0!@  G"<  !,
M ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  -A$5:B GA
M&,@&   Z*0  &               @($-"   >&PO=V]R:W-H965T<R]S:&5E
M=#$N>&UL4$L! A0#%     @ #81%6I^@&_"Q @  X@P   T
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;72YX;6Q02P4&      D "0 ^ @  8Q8

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>9</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>9</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="bdx-20250205.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bd.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="bdx-20250205.htm">bdx-20250205.htm</File>
    <File>bdx-20250205.xsd</File>
    <File>bdx-20250205_def.xml</File>
    <File>bdx-20250205_lab.xml</File>
    <File>bdx-20250205_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="43">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "bdx-20250205.htm": {
   "nsprefix": "bdx",
   "nsuri": "http://www.bd.com/20250205",
   "dts": {
    "inline": {
     "local": [
      "bdx-20250205.htm"
     ]
    },
    "schema": {
     "local": [
      "bdx-20250205.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "bdx-20250205_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "bdx-20250205_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bdx-20250205_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 2,
   "memberCustom": 7,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 9,
   "entityCount": 1,
   "segmentCount": 9,
   "elementCount": 38,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 43
   },
   "report": {
    "R1": {
     "role": "http://www.bd.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bdx-20250205.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bdx-20250205.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitiesTable",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entities [Table]",
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Information [Line Items]",
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Listings, Exchange [Axis]",
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange [Domain]",
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "bdx_Notes0034DueAugust132025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bd.com/20250205",
     "localname": "Notes0034DueAugust132025Member",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes 0.034% due August 13, 2025",
        "label": "Notes 0.034% due August 13, 2025 [Member]",
        "documentation": "Notes 0.034% due August 13, 2025"
       }
      }
     },
     "auth_ref": []
    },
    "bdx_Notes1.208dueJune42026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bd.com/20250205",
     "localname": "Notes1.208dueJune42026Member",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes 1.208% due June 4, 2026",
        "label": "Notes 1.208% due June 4, 2026 [Member]",
        "documentation": "Notes 1.208% due June 4, 2026 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "bdx_Notes1.900dueDecember152026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bd.com/20250205",
     "localname": "Notes1.900dueDecember152026Member",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes 1.900% due December 15, 2026",
        "label": "Notes 1.900% due December 15, 2026 [Member]",
        "documentation": "Notes 1.900% due December 15, 2026 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "bdx_Notes1213DueFebruary122036Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bd.com/20250205",
     "localname": "Notes1213DueFebruary122036Member",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes 1.213% due February 12, 2036",
        "label": "Notes 1.213% due February 12, 2036 [Member]",
        "documentation": "Notes 1.213% due February 12, 2036"
       }
      }
     },
     "auth_ref": []
    },
    "bdx_Notes3.020dueMay242025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bd.com/20250205",
     "localname": "Notes3.020dueMay242025Member",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes 3.020% due May 24, 2025",
        "label": "Notes 3.020% due May 24, 2025 [Member]",
        "documentation": "Notes 3.020% due May 24, 2025 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "bdx_Notes3.519DueFebruary82031Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bd.com/20250205",
     "localname": "Notes3.519DueFebruary82031Member",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes 3.519% due February 8, 2031",
        "label": "Notes 3.519% due February 8, 2031 [Member]",
        "documentation": "Notes 3.519% due February 8, 2031"
       }
      }
     },
     "auth_ref": []
    },
    "bdx_Notes3.828DueJune72032Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bd.com/20250205",
     "localname": "Notes3.828DueJune72032Member",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes 3.828% due June 7, 2032",
        "label": "Notes 3.828% due June 7, 2032 [Member]",
        "documentation": "Notes 3.828% due June 7, 2032"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "exch_XNYS": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/exch/2024",
     "localname": "XNYS",
     "presentation": [
      "http://www.bd.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NEW YORK STOCK EXCHANGE, INC.",
        "label": "NEW YORK STOCK EXCHANGE, INC. [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0000010795-25-000019-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000010795-25-000019-xbrl.zip
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MX>AOL/!-TEI^OL!M*]:C+W6!;?_.J!@/&[3!4Z&4C1E=%G3)HHQ,L9;%PHX
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M$T#HN:I(-#\+$%=T3#3CA=1>!VQ80.;%V&#$V'"@Y48LNS8P% [ L)+*A4S
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M&$@YESQ,YEO+4PC:8B6?&S3/Y'S(WU.?,:PBE.A#*%QNCYV/%]:]I6DE])C
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MN*F"2O-FX8[),<[L'T 00P!+RD!!. -(4T[MP$0)E'D/2G8,GWI,TDPH6:S
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M1'N#V.+NH[Z:NP?;R[I9K\J*5*;*Z@$JF ),,0<"X1P0165.M2R0)F$UW3[
M-*7< V;@&M[6F/C6;?%,H\HU7Y(115H[DQ&UV2.#$Y=D[70.*[&.=N'2^E!I
M-PS3UC^7NR[=Z3#5>V/<H"G5TA#-@,*< YQ!; NQ7 &124J0@21#WIO-NF%.
M+#,+#.0.<K*&3AIL?[7UA&E8<\<A'Z:\.-Y! ARF%27#'K.3B7&8VJXD/5I'
M+U,@*=M9 E$@F*7;&414((FA KE6MC+D@MG*,+7RY*00)LTRJHO I0J=8!,M
M5[#XCY;5%,T3ZC3X:7UWV/KE>NQ@A(EV, [QRQ>Z Q*\A.$H@1FWC"'\1HE9
MRC!(='@Y0[>)J9<T#))I6=8P?$UL+?_Z1E=7=FCPCZK\7E_;WO,K7_Z8J;3
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M9I99E$"8L#BN)AQK+4V2!' ZH6OXOAJ9E9][,0TD(X>W'%7K3:"E7"[+5>?
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M,/.+/;>*5N=BC28W7$\/+-<YFS@F]W#43[]=P;NZ$?@?/]2:YP>#\H5D4&O
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M<C/1E6)^\_B)!;/-@EJI44V4)IQ?%CQ ?G<Z>0M:LGB$H[GL)7;9!;L<I!Y
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M;%N'.QF&JN5?&!P22.*198Y="W1/@,+RYX-U9V'-$5CB0V5%;=3"6Q[D%%?
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M[4[]@(^.VG-;4+.GJJ9H]I!%^BII*N3'R2AI/GYH:JJV@SL>(L]>FM%7%.U
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MY$E\5)NB+9& PG),[@1GIZIH5;0KFK3>(HDFC<1*];QS*_[#  PWX#X+AGH
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MCLE^KM2UV1_&'@8-_B@QC_MC;F#PL3W]Q"(<[F0E=:668"DKHJ"1#4\KRHH
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M6'<"\\MOC?3IC.4BL$() 1PT O$>:^=5F@VQ^0"89Z0' ?=B?[:<)RZ-9C:
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MV)7'??'HYY"-9O#K(9SX'_\/4$L! A0#%     @ #81%6ER/G#S((@  /9D
M !X              ( !     &)D7VYE=W-X8F1B>&1S>'-E<&%R871I;VYP
M+FAT;5!+ 0(4 Q0    (  V$15KRG7AUQA0  (JM   0              "
M 00C  !B9'@M,C R-3 R,#4N:'1M4$L! A0#%     @ #81%6LD!=[>[ P
MD!   !               ( !^#<  &)D>"TR,#(U,#(P-2YX<V102P$"% ,4
M    "  -A$5:P&"BH4 *  !E3@  %               @ 'A.P  8F1X+3(P
M,C4P,C U7V1E9BYX;6Q02P$"% ,4    "  -A$5:TBW1+'D0  #=D0  %
M            @ %31@  8F1X+3(P,C4P,C U7VQA8BYX;6Q02P$"% ,4
M"  -A$5:/4/F2^T)   V40  %               @ '^5@  8F1X+3(P,C4P
M,C U7W!R92YX;6Q02P$"% ,4    "  -A$5:WJ<*0RQT  #2T @ $0
M        @ $=80  97@Y.3$Q,C,Q,C R-"YH=&U02P4&      < !P#- 0
&>-4

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>bdx-20250205_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bdx="http://www.bd.com/20250205"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:exch="http://xbrl.sec.gov/exch/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bdx-20250205.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
        </entity>
        <period>
            <startDate>2025-02-05</startDate>
            <endDate>2025-02-05</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-05</startDate>
            <endDate>2025-02-05</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.900dueDecember152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-05</startDate>
            <endDate>2025-02-05</endDate>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes3.020dueMay242025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-05</startDate>
            <endDate>2025-02-05</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.208dueJune42026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-05</startDate>
            <endDate>2025-02-05</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1213DueFebruary122036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-05</startDate>
            <endDate>2025-02-05</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0034DueAugust132025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-05</startDate>
            <endDate>2025-02-05</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes3.519DueFebruary82031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-05</startDate>
            <endDate>2025-02-05</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010795</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes3.828DueJune72032Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-05</startDate>
            <endDate>2025-02-05</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-42">0000010795</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-43">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-02-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">BECTON, DICKINSON AND COMPANY</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">NJ</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-4802</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">22-0760120</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">1 Becton Drive,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Franklin Lakes,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">07417-1880</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">(201)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">847-6800</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-2" id="f-17">Common stock, par value $1.00</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-2" id="f-18">BDX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-2" id="f-19">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-3" id="f-20">1.900% Notes due December 15, 2026</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-3" id="f-21">BDX26</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-3" id="f-22">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-4" id="f-23">3.020% Notes due May 24, 2025</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-4" id="f-24">BDX25</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-4" id="f-25">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-5" id="f-26">1.208% Notes due June 4, 2026</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-5" id="f-27">BDX/26A</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-5" id="f-28">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-6" id="f-29">1.213% Notes due February 12, 2036</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-6" id="f-30">BDX/36</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-6" id="f-31">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-7" id="f-32">0.034% Notes due August 13, 2025</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-7" id="f-33">BDX25A</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-7" id="f-34">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-8" id="f-35">3.519% Notes due February 8, 2031</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-8" id="f-36">BDX31</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-8" id="f-37">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-9" id="f-38">3.828% Notes due June 7, 2032</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-9" id="f-39">BDX32A</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-9" id="f-40">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-41">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
